BLASTP 2.12.0+


Reference: Stephen F. Altschul, Thomas L. Madden, Alejandro A.
Schaffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and David J.
Lipman (1997), "Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs", Nucleic Acids Res. 25:3389-3402.


Reference for composition-based statistics: Alejandro A. Schaffer,
L. Aravind, Thomas L. Madden, Sergei Shavirin, John L. Spouge, Yuri
I. Wolf, Eugene V. Koonin, and Stephen F. Altschul (2001),
"Improving the accuracy of PSI-BLAST protein database searches with
composition-based statistics and other refinements", Nucleic Acids
Res. 29:2994-3005.



Database: VFDB_setB_pro.fas
           27,982 sequences; 13,298,383 total letters



Query= g284.t1

Length=333
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  100     6e-24
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  100     9e-24
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  100     9e-24
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  100     1e-23
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  100     1e-23
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  99.8    1e-23
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  99.8    1e-23
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  99.8    2e-23
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  99.8    2e-23
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  99.8    2e-23
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  98.2    5e-23
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  96.3    3e-22
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  79.0    1e-16
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  51.6    3e-07
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  51.6    3e-07
VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC [M...  50.4    6e-07
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  50.1    9e-07
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  50.1    9e-07
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  50.1    9e-07
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  50.1    9e-07
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  50.1    9e-07
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  50.1    1e-06
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  49.3    2e-06
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  49.3    2e-06
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  49.3    2e-06
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  48.5    3e-06


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 100 bits (250),  Expect = 6e-24, Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 143/300 (48%), Gaps = 13/300 (4%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQEQDQVFATRDQSH  157
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q+ 
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARTAVSQAQ  168

Query  158  AEHEQLQAAIQQAEATIK-----QQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFD  212
            A  +   A    A A +      ++Q  V+ A   L  A LN+ R  V APADG ++   
Sbjct  169  AAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQVAKRS  228

Query  213  LRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGHVQ  270
            ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  271  GIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATVHI  330
            G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV +
Sbjct  289  GFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  343


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 100 bits (249),  Expect = 9e-24, Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 148/302 (49%), Gaps = 17/302 (6%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQE-------QDQVF  150
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q  
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  151  ATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSN  210
            A    + AE    +AA+   + ++++Q A V+ A   L  A LN+ R  + APADG ++ 
Sbjct  169  AAVKAALAEESSARAAL-GGQVSLREQPA-VQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  211  FDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGH  268
              ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  269  VQGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATV  328
            V G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV
Sbjct  287  VAGFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  329  HI  330
             +
Sbjct  342  KV  343


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 100 bits (249),  Expect = 9e-24, Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 148/302 (49%), Gaps = 17/302 (6%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQE-------QDQVF  150
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q  
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  151  ATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSN  210
            A    + AE    +AA+   + ++++Q A V+ A   L  A LN+ R  + APADG ++ 
Sbjct  169  AAVKAALAEESSARAAL-GGQVSLREQPA-VQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  211  FDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGH  268
              ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  269  VQGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATV  328
            V G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV
Sbjct  287  VAGFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  329  HI  330
             +
Sbjct  342  KV  343


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 100 bits (248),  Expect = 1e-23, Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 148/302 (49%), Gaps = 17/302 (6%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQE-------QDQVF  150
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q  
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  151  ATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSN  210
            A    + AE    +AA+   + ++++Q A V+ A   L  A LN+ R  + APADG ++ 
Sbjct  169  AAVKAALAEESSARAAL-GGQVSLREQPA-VQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  211  FDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGH  268
              ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  269  VQGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATV  328
            V G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV
Sbjct  287  VAGFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  329  HI  330
             +
Sbjct  342  KV  343


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 100 bits (248),  Expect = 1e-23, Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 148/302 (49%), Gaps = 17/302 (6%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQE-------QDQVF  150
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q  
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  151  ATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSN  210
            A    + AE    +AA+   + ++++Q A V+ A   L  A LN+ R  + APADG ++ 
Sbjct  175  AAVKAALAEESSARAAL-GGQVSLREQPA-VQTAIGRLKDAWLNLQRTQIRAPADGQVAK  232

Query  211  FDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGH  268
              ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G 
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  292

Query  269  VQGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATV  328
            V G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV
Sbjct  293  VAGFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  347

Query  329  HI  330
             +
Sbjct  348  KV  349


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 99.8 bits (247),  Expect = 1e-23, Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 144/300 (48%), Gaps = 13/300 (4%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQEQDQVFATRDQSH  157
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E     A   Q+ 
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  158  AEHEQLQAAIQQAEATIKQQQAL-----VEAATSNLHLAELNMHRAAVVAPADGTLSNFD  212
            A  +   A    A A +  Q +L     V+ A   L  A LN+ R  + APADG ++   
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  234

Query  213  LRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGHVQ  270
            ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  294

Query  271  GIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATVHI  330
            G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV +
Sbjct  295  GFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  349


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 99.8 bits (247),  Expect = 1e-23, Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 148/302 (49%), Gaps = 17/302 (6%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQE-------QDQVF  150
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q  
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  151  ATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSN  210
            A    + AE    +AA+   + ++++Q A V+ A   L  A LN+ R  + APADG ++ 
Sbjct  169  AAVKAALAEESSARAAL-GGQVSLREQPA-VQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  211  FDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGH  268
              ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  269  VQGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATV  328
            V G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV
Sbjct  287  VAGFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  329  HI  330
             +
Sbjct  342  KV  343


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 99.8 bits (247),  Expect = 2e-23, Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 148/302 (49%), Gaps = 17/302 (6%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQE-------QDQVF  150
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q  
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  151  ATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSN  210
            A    + AE    +AA+   + ++++Q A V+ A   L  A LN+ R  + APADG ++ 
Sbjct  169  AAVKAALAEESSARAAL-GGQVSLREQPA-VQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  211  FDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGH  268
              ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  269  VQGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATV  328
            V G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV
Sbjct  287  VAGFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  329  HI  330
             +
Sbjct  342  KV  343


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 99.8 bits (247),  Expect = 2e-23, Method: Compositional matrix adjust.
 Identities = 92/300 (31%), Positives = 143/300 (48%), Gaps = 13/300 (4%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQEQDQVFATRDQSH  157
                 Q  A  +QA A +     ++  A+ +  R S L + GA+S +E     A   Q+ 
Sbjct  115  VRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  158  AEHEQLQAAIQQAEATIKQQQAL-----VEAATSNLHLAELNMHRAAVVAPADGTLSNFD  212
            A  +   A    A A +  Q AL     V+ A   L  A LN+ R  + AP DG ++   
Sbjct  175  AAVKAALAEESSARAALGGQVALREQPAVQTAIGRLKDAWLNLQRTQIRAPTDGQVAKRS  234

Query  213  LRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGHVQ  270
            ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGMVA  294

Query  271  GIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATVHI  330
            G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV +
Sbjct  295  GFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  349


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 99.8 bits (247),  Expect = 2e-23, Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 148/302 (49%), Gaps = 17/302 (6%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQE-------QDQVF  150
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q  
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  151  ATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSN  210
            A    + AE    +AA+   + ++++Q A V+ A   L  A LN+ R  + APADG ++ 
Sbjct  175  AAVKAALAEESSARAAL-GGQVSLREQPA-VQTAIGRLKDAWLNLQRTQIRAPADGQVAK  232

Query  211  FDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGH  268
              ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G 
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  292

Query  269  VQGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATV  328
            V G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV
Sbjct  293  VAGFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  347

Query  329  HI  330
             +
Sbjct  348  KV  349


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 98.2 bits (243),  Expect = 5e-23, Method: Compositional matrix adjust.
 Identities = 90/302 (30%), Positives = 147/302 (49%), Gaps = 17/302 (6%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQE-------QDQVF  150
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q  
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  151  ATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSN  210
            A    + AE    +AA+   + ++++Q A V+ A   L  A LN+ R  +  PADG ++ 
Sbjct  169  AAVKAALAEESSARAAL-GGQVSLREQPA-VQTAIGRLKDAWLNLQRTQIRTPADGQVAK  226

Query  211  FDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGH  268
              ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  269  VQGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATV  328
            V G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV
Sbjct  287  VAGFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  329  HI  330
             +
Sbjct  342  KV  343


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 96.3 bits (238),  Expect = 3e-22, Method: Compositional matrix adjust.
 Identities = 90/302 (30%), Positives = 147/302 (49%), Gaps = 17/302 (6%)

Query  39   TRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKA  98
            T D  V G V+QV+    G V +VL  D   VKKG VL  +D     L  E+AK++L +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  99   KAAYAQAQAGLAQAKANLIKSSTNIKLAEKNANRYSNLMD-GAISKQE-------QDQVF  150
                 +  A  +QA A +     ++  A+ +  R S L + GA+S +E         Q  
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  151  ATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSN  210
            A    + AE    +AA+   + ++++Q A V+ A   L  A LN+ R  + A ADG ++ 
Sbjct  175  AAVKAALAEESSARAAL-GGQVSLREQPA-VQTAIGRLKDAWLNLQRTQIRASADGQVAK  232

Query  211  FDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHIGDEATV--QLMGDRQKIKGH  268
              ++ G  V  G  + A++    ++V   F+ET+L  + IG  A +   L G +   +G 
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  292

Query  269  VQGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPVKIVLDEAPKNELAFVSGRTATV  328
            V G ++G       S+  L+   N T +W+++ QRVPV+IVL+    +      G + TV
Sbjct  293  VAGFSAGT-----GSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  347

Query  329  HI  330
             +
Sbjct  348  KV  349


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 79.0 bits (193),  Expect = 1e-16, Method: Compositional matrix adjust.
 Identities = 73/324 (23%), Positives = 153/324 (47%), Gaps = 17/324 (5%)

Query  17   VALMIAVYTIVHLWNYYNAAPWTRDGRVRGDVIQVSSDVAGLVTEVLVQDNQTVKKGQVL  76
            V +++ V+  + +++Y    P+T +  V  +V  V+++V G +T + V++ Q VKKGQ L
Sbjct  11   VIILLCVFLFILIYHYSYLFPFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKKGQPL  70

Query  77   FKIDVSRRALDVEQAKSDLAKAKAAY------AQAQAGLAQAKANLIKSSTNIKLAEKNA  130
            F +  +   L   +A S + +AKA         +    L QA+  L +     K      
Sbjct  71   FTVFKAPYELAYRKAVSHVQEAKAQLLLFNKQVEKTKYLLQAQKELYE-----KFRFDYE  125

Query  131  NRYSNLMDGAISKQEQDQVFATRDQSHAEHEQLQAAIQQAEATIKQQQALVEAATSNLHL  190
            + YS   D A+SK   + +   ++ + ++ + L+  ++  +  +  Q+  +++  + +  
Sbjct  126  HNYSASRDHAVSKLTVNTMLKEKNAALSKLKALEKELEVNQQQVIVQKKKIDSLIAVMKN  185

Query  191  AELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQAVAALLDRKQLYVVGYFEETKLDRIHI  250
            A++++    V A  +G + +  +  G  ++  + V A+ D   L++   F ET L R+  
Sbjct  186  AKIDLDETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQANFNETDLRRVQP  245

Query  251  GDEATV-QLMGDRQKIKGHV---QGIASGIEDRERSSSSKLLANVNPTFSWVRLAQRVPV  306
            GD+ ++   M    KI   V   +  A+   +  R++  +++ N     +W  L QR+PV
Sbjct  246  GDKVSIFPRMYFGSKIYHGVILSRNWAASRLETHRATQIQIVRNSES--NWFLLPQRLPV  303

Query  307  KIVLDEAPKNELAFVSGRTATVHI  330
            +I + +          G +A V+I
Sbjct  304  QIQITDYDPVHYPLSIGASAYVYI  327


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 51.6 bits (122),  Expect = 3e-07, Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 81/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S     +E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   AISKQE D     +              + 
Sbjct  135  ---------------------RYKPLVSADAISKQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 51.6 bits (122),  Expect = 3e-07, Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 43/173 (25%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S     +E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   AISKQE D     +              + 
Sbjct  135  ---------------------RYKPLVSADAISKQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVG  222
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAG  205


>VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240355]
Length=412

 Score = 50.4 bits (119),  Expect = 6e-07, Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S     +E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEASLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   AISKQE D     +              + 
Sbjct  135  ---------------------RYKPLVAADAISKQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        ++++R+ + AP  G +    +  G  +  G A  +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------ISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 50.1 bits (118),  Expect = 9e-07, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S    ++E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 50.1 bits (118),  Expect = 9e-07, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S    ++E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 50.1 bits (118),  Expect = 9e-07, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S    ++E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 50.1 bits (118),  Expect = 9e-07, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S    ++E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 50.1 bits (118),  Expect = 9e-07, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S    ++E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 50.1 bits (118),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S    ++E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 49.3 bits (116),  Expect = 2e-06, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S     +E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 49.3 bits (116),  Expect = 2e-06, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S     +E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 49.3 bits (116),  Expect = 2e-06, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S     +E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        +N++R+ + AP  G +    +  G  +  G    +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------INLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 48.5 bits (114),  Expect = 3e-06, Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (24%)

Query  51   VSSDVAGLVTEVLVQDNQTVKKGQVLFKIDVSRRALDVEQAKSDLAKAKAAYAQAQAGLA  110
            V + V G++ + L Q+   V+ GQ L++ID S     +E A++ LA A+A  A+A A LA
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  111  QAKANLIKSSTNIKLAEKNANRYSNLMDG-AISKQEQDQVFATRDQSHAEHEQLQAAIQQ  169
                                 RY  L+   A+S+QE D     +              + 
Sbjct  135  ---------------------RYKPLVAAEAVSRQEYDAAVTAK--------------RS  159

Query  170  AEATIKQQQALVEAATSNLHLAELNMHRAAVVAPADGTLSNFDLRPGNYVQVGQA--VAA  227
            AEA +K  QA +++A        ++++R+ + AP  G +    +  G  +  G A  +A 
Sbjct  160  AEAGVKAAQAAIKSAG-------ISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLAT  212

Query  228  LLDRKQLYV  236
            +     +YV
Sbjct  213  IRQTNPMYV  221



Lambda      K        H        a         alpha
   0.316    0.129    0.350    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2429550632


Query= g1246.t1

Length=302
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  95.5    3e-22
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  92.0    5e-21
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  91.7    6e-21
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  92.0    6e-21
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  91.7    7e-21
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  91.7    7e-21
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  91.3    8e-21
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  91.3    8e-21
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  91.3    8e-21
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  91.3    9e-21
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  90.5    2e-20
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  88.2    1e-19
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  70.1    2e-13
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  70.1    2e-13
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  69.7    2e-13
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  69.7    2e-13
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  69.3    3e-13
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  68.6    7e-13
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  68.2    8e-13
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  68.2    8e-13
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  67.8    8e-13
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  67.8    1e-12
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  67.4    1e-12
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  67.4    1e-12
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  67.4    1e-12
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  67.4    1e-12
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  67.4    1e-12
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  67.0    2e-12
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  67.0    2e-12
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  65.1    8e-12
VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC [M...  64.7    1e-11


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 95.5 bits (236),  Expect = 3e-22, Method: Compositional matrix adjust.
 Identities = 96/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRAL----  128
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARTAVSQAQ  168

Query  129  --------RIARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+LRR+++R+P DG V +  
Sbjct  169  AAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQVAKRS  228

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  289  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  341

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  342  KVDTSAAG  349


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 92.0 bits (227),  Expect = 5e-21, Method: Compositional matrix adjust.
 Identities = 87/282 (31%), Positives = 129/282 (46%), Gaps = 56/282 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  96   RETLRQRD---------------------EQWRRRMQLA--GAVSREEVANAGRALRI--  130
                RQ++                     +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  115  VRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  175  AAVKAALAEESSARAALGGQVALREQPAVQTAIGRLKDAWLNLQRTQIRAPTDGQVAKRS  234

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGMVA  294

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRIELDR  266
                G        A S +P  +   +WI++ QRVPVRI L+R
Sbjct  295  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNR  331


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 91.7 bits (226),  Expect = 6e-21, Method: Compositional matrix adjust.
 Identities = 95/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  289  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  341

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  342  KVDTSAAG  349


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 92.0 bits (227),  Expect = 6e-21, Method: Compositional matrix adjust.
 Identities = 95/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  234

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  294

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  295  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  347

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  348  KVDTSAAG  355


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 91.7 bits (226),  Expect = 7e-21, Method: Compositional matrix adjust.
 Identities = 95/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  289  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  341

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  342  KVDTSAAG  349


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 91.7 bits (226),  Expect = 7e-21, Method: Compositional matrix adjust.
 Identities = 95/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRTPADGQVAKRS  228

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  289  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  341

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  342  KVDTSAAG  349


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 91.3 bits (225),  Expect = 8e-21, Method: Compositional matrix adjust.
 Identities = 95/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  289  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  341

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  342  KVDTSAAG  349


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 91.3 bits (225),  Expect = 8e-21, Method: Compositional matrix adjust.
 Identities = 95/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  289  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  341

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  342  KVDTSAAG  349


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 91.3 bits (225),  Expect = 8e-21, Method: Compositional matrix adjust.
 Identities = 95/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  234

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  294

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  295  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  347

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  348  KVDTSAAG  355


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 91.3 bits (225),  Expect = 9e-21, Method: Compositional matrix adjust.
 Identities = 95/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  234

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  294

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  295  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  347

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  348  KVDTSAAG  355


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 90.5 bits (223),  Expect = 2e-20, Method: Compositional matrix adjust.
 Identities = 95/308 (31%), Positives = 140/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+P DG V +  
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  289  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  341

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  342  KVDTSAAG  349


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 88.2 bits (217),  Expect = 1e-19, Method: Compositional matrix adjust.
 Identities = 94/308 (31%), Positives = 139/308 (45%), Gaps = 63/308 (20%)

Query  36   TRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQA  95
            T D  V+ +V+++ P+  G+V  V   D   V +GD L  +D  +  LA  + + EL QA
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  96   -RETLRQR--------------------DEQWRRRMQLA--GAVSREEVANAGRALRI--  130
             R+  RQ                      +  RRR  LA  GAVS EE+A+A  A+    
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  131  ----------ARARAEAAGAA--------------LDQARLDLRRSELRSPVDGYVTQLR  166
                      + ARA   G                L  A L+L+R+++R+  DG V +  
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRASADGQVAKRS  234

Query  167  VQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--KLMGFDPLLDGHVA  224
            VQ G   AAG   + +V     WV   F+ET+LR++++G PA +   L G   +  G VA
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  294

Query  225  SIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRI-----ELDRVPAGVVLAAGMTG  279
                G        A S +P  +   +WI++ QRVPVRI     ++DR P  + L+  MT 
Sbjct  295  GFSAGTGS-----AFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS--MTV  347

Query  280  SVEVLQAG  287
             V+   AG
Sbjct  348  KVDTSAAG  355


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 70.1 bits (170),  Expect = 2e-13, Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (51%), Gaps = 10/154 (6%)

Query  27   WQAYVLAPWTRDGRVSA-QVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAV  85
            WQ Y        GR+ A   + I P+VSG + AV   D   V +GD L+ IDPR +   +
Sbjct  59   WQEY-------SGRLEAIDQVDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDPRPFEAEL  111

Query  86   RQREAELEQARETLRQRDEQWRR--RMQLAGAVSREEVANAGRALRIARARAEAAGAALD  143
             + +A+L  A   +        R  R+  + AVSR+E+  A    R A A  +AA AA+ 
Sbjct  112  NRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQ  171

Query  144  QARLDLRRSELRSPVDGYVTQLRVQPGDYAAAGR  177
             ARL+L  + + +PV G +++  V  G+  +AG 
Sbjct  172  SARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  205


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 70.1 bits (170),  Expect = 2e-13, Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (51%), Gaps = 10/154 (6%)

Query  27   WQAYVLAPWTRDGRVSA-QVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAV  85
            WQ Y        GR+ A   + I P+VSG + AV   D   V +GD L+ IDPR +   +
Sbjct  59   WQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAEL  111

Query  86   RQREAELEQARETLRQRDEQWRR--RMQLAGAVSREEVANAGRALRIARARAEAAGAALD  143
             + +A+L  A   +        R  R+  + AVSR+E+  A    R A A  +AA AA+ 
Sbjct  112  NRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQ  171

Query  144  QARLDLRRSELRSPVDGYVTQLRVQPGDYAAAGR  177
             ARL+L  + + +PV G +++  V  G+  +AG 
Sbjct  172  SARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  205


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 69.7 bits (169),  Expect = 2e-13, Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (51%), Gaps = 10/154 (6%)

Query  27   WQAYVLAPWTRDGRVSA-QVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAV  85
            WQ Y        GR+ A   + I P+VSG + AV   D   V +GD L+ IDPR +   +
Sbjct  59   WQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAEL  111

Query  86   RQREAELEQARETLRQRDEQWRR--RMQLAGAVSREEVANAGRALRIARARAEAAGAALD  143
             + +A+L  A   +        R  R+  + AVSR+E+  A    R A A  +AA AA+ 
Sbjct  112  NRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQ  171

Query  144  QARLDLRRSELRSPVDGYVTQLRVQPGDYAAAGR  177
             ARL+L  + + +PV G +++  V  G+  +AG 
Sbjct  172  SARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  205


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 69.7 bits (169),  Expect = 2e-13, Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (51%), Gaps = 10/154 (6%)

Query  27   WQAYVLAPWTRDGRVSA-QVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAV  85
            WQ Y        GR+ A   + I P+VSG + AV   D   V +GD L+ IDPR +   +
Sbjct  59   WQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAEL  111

Query  86   RQREAELEQARETLRQRDEQWRR--RMQLAGAVSREEVANAGRALRIARARAEAAGAALD  143
             + +A+L  A   +        R  R+  + AVSR+E+  A    R A A  +AA AA+ 
Sbjct  112  NRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQ  171

Query  144  QARLDLRRSELRSPVDGYVTQLRVQPGDYAAAGR  177
             ARL+L  + + +PV G +++  V  G+  +AG 
Sbjct  172  SARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  205


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 69.3 bits (168),  Expect = 3e-13, Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (51%), Gaps = 10/154 (6%)

Query  27   WQAYVLAPWTRDGRVSA-QVIRIAPEVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAV  85
            WQ Y        GR+ A   + I P+VSG + AV   D   V +GD L+ IDPR +   +
Sbjct  35   WQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAEL  87

Query  86   RQREAELEQARETLRQRDEQWRR--RMQLAGAVSREEVANAGRALRIARARAEAAGAALD  143
             + +A+L  A   +        R  R+  + AVSR+E+  A    R A A  +AA AA+ 
Sbjct  88   NRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQ  147

Query  144  QARLDLRRSELRSPVDGYVTQLRVQPGDYAAAGR  177
             ARL+L  + + +PV G +++  V  G+  +AG 
Sbjct  148  SARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  181


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 68.6 bits (166),  Expect = 7e-13, Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 68.2 bits (165),  Expect = 8e-13, Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 68.2 bits (165),  Expect = 8e-13, Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 67.8 bits (164),  Expect = 8e-13, Method: Compositional matrix adjust.
 Identities = 68/314 (22%), Positives = 128/314 (41%), Gaps = 47/314 (15%)

Query  17   LLALCLALQLWQAYVLAPWTRDGRVSAQVIRIAPEVSGSVEAVFVADNQRVARGDPLYRI  76
            LL + L + ++    L P+T +  V A V  +A  V G +  ++V + Q V +G PL+ +
Sbjct  14   LLCVFLFILIYHYSYLFPFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKKGQPLFTV  73

Query  77   DPRSYRLAVRQREAELEQARETL-----------------RQRDEQWRRRMQLAGAVSRE  119
                Y LA R+  + +++A+  L                 ++  E++R   +   + SR+
Sbjct  74   FKAPYELAYRKAVSHVQEAKAQLLLFNKQVEKTKYLLQAQKELYEKFRFDYEHNYSASRD  133

Query  120  EVA------------NAG----RALR-----------IARARAEAAGAALDQARLDLRRS  152
                           NA     +AL            + + + ++  A +  A++DL  +
Sbjct  134  HAVSKLTVNTMLKEKNAALSKLKALEKELEVNQQQVIVQKKKIDSLIAVMKNAKIDLDET  193

Query  153  ELRSPVDGYVTQLRVQPGDYAAAGRTNIFIVDRRSFWVTGYFEETKLRNVQVGAPATI--  210
             + +  +G V  + V  G      +    I D  + ++   F ET LR VQ G   +I  
Sbjct  194  TVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQANFNETDLRRVQPGDKVSIFP  253

Query  211  KLMGFDPLLDGHVASIGRGVADLNESRADSGLPQVSPNFSWIRLAQRVPVRIEL-DRVPA  269
            ++     +  G + S     + L   RA       +   +W  L QR+PV+I++ D  P 
Sbjct  254  RMYFGSKIYHGVILSRNWAASRLETHRATQIQIVRNSESNWFLLPQRLPVQIQITDYDPV  313

Query  270  GVVLAAGMTGSVEV  283
               L+ G +  V +
Sbjct  314  HYPLSIGASAYVYI  327


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 67.8 bits (164),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 67.4 bits (163),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 67.4 bits (163),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 67.4 bits (163),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 67.4 bits (163),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 67.4 bits (163),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 67.0 bits (162),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 44/139 (32%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A A+S++E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVSADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 67.0 bits (162),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 44/139 (32%), Positives = 70/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A A+S++E   A  A R A A  +AA AA+  A ++L RS + +P+ G++ Q +V 
Sbjct  138  PLVSADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG T +    R++
Sbjct  198  EGTLLNAGDTTVLATIRQT  216


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 65.1 bits (157),  Expect = 8e-12, Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 68/139 (49%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y   +    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A AVSR+E   A  A R A A  +AA AA+  A + L RS + +P+ G++ Q +V 
Sbjct  138  PLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG   +    R++
Sbjct  198  EGTLLNAGDATVLATIRQT  216


>VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240355]
Length=412

 Score = 64.7 bits (156),  Expect = 1e-11, Method: Compositional matrix adjust.
 Identities = 43/139 (31%), Positives = 69/139 (50%), Gaps = 2/139 (1%)

Query  51   EVSGSVEAVFVADNQRVARGDPLYRIDPRSYRLAVRQREAELEQARETLRQRDEQWRRRM  110
            +V G ++     +   V  G PLY+ID  +Y  ++    A+L  A+ TL + D    R  
Sbjct  78   QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEASLESARAQLATAQATLAKADADLARYK  137

Query  111  QL--AGAVSREEVANAGRALRIARARAEAAGAALDQARLDLRRSELRSPVDGYVTQLRVQ  168
             L  A A+S++E   A  A R A A  +AA AA+  A + L RS + +P+ G++ Q +V 
Sbjct  138  PLVAADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVS  197

Query  169  PGDYAAAGRTNIFIVDRRS  187
             G    AG   +    R++
Sbjct  198  EGTLLNAGDATVLATIRQT  216



Lambda      K        H        a         alpha
   0.322    0.135    0.399    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2121036966


Query= g2469.t1

Length=334
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  100     9e-24
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  97.1    1e-22
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  97.1    2e-22
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  95.9    4e-22
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  95.5    5e-22
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  95.1    7e-22
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  94.7    8e-22
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  94.7    9e-22
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  94.7    1e-21
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  94.7    1e-21
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  93.2    3e-21
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  91.3    9e-21
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  91.3    2e-20
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  61.2    2e-10
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  61.2    2e-10
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  61.2    2e-10
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  61.2    2e-10
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  60.8    3e-10
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  47.0    9e-06
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  47.0    1e-05


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 100 bits (249),  Expect = 9e-24, Method: Compositional matrix adjust.
 Identities = 101/318 (32%), Positives = 154/318 (48%), Gaps = 28/318 (9%)

Query  37   TRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAE----RA  92
            T DA V   VV ++    G + ++   D   V+KG++L  +D     LA  RA+    +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  93   VNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEENEKAQTDVS---  146
            V   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE   A+T VS   
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARTAVSQAQ  168

Query  147  ----LAQAELLRNQASLG-----LAQANVELAEAALQQARLDLERTQVRAPVSGYVTNLQ  197
                 A AE    +A+LG       Q  V+ A   L+ A L+L RTQVRAP  G V    
Sbjct  169  AAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQVAKRS  228

Query  198  TREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELMSGER--FDGRVQ  254
             + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  + G++  + GRV 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  255  SIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRNTLRAGVTATIRV  314
              +             L+   N +  W+K+ QR+PVRI ++     R+ LR G++ T++V
Sbjct  289  GFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  343

Query  315  LPAEDTAKVDSAAPGTAL  332
              +   A V S  PG AL
Sbjct  344  DTSAAGAPV-SKTPGAAL  360


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 97.1 bits (240),  Expect = 1e-22, Method: Compositional matrix adjust.
 Identities = 101/332 (30%), Positives = 157/332 (47%), Gaps = 35/332 (11%)

Query  25   FLAWERYTRTPWTRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYEL  84
            FL W+    T    DA V   VV ++    G + ++   D   V+KG++L  +D     L
Sbjct  46   FLWWQHEEET---EDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVL  102

Query  85   AVLRAE----RAVNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE  137
            A  RA+    +AV   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE
Sbjct  103  AYERAKNELIQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  138  --------------NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERT  183
                           + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RT
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARA-ALGGQVSL-REQPAVQTAIGRLKDAWLNLQRT  220

Query  184  QVRAPVSGYVTNLQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VE  242
            Q+RAP  G V     + G    AG PL+A+V     +V   F+ET+L  + +G  A  V 
Sbjct  221  QIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVS  280

Query  243  LMSGER--FDGRVQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQ  300
             + G++  + GRV   +             L+   N +  W+K+ QR+PVRI ++     
Sbjct  281  DLYGKQIVYRGRVAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVD  335

Query  301  RNTLRAGVTATIRVLPAEDTAKVDSAAPGTAL  332
            R+ LR G++ T++V  +   A V S  PG AL
Sbjct  336  RHPLRIGLSMTVKVDTSAAGAPV-SKTPGAAL  366


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 97.1 bits (240),  Expect = 2e-22, Method: Compositional matrix adjust.
 Identities = 101/332 (30%), Positives = 157/332 (47%), Gaps = 35/332 (11%)

Query  25   FLAWERYTRTPWTRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYEL  84
            FL W+    T    DA V   VV ++    G + ++   D   V+KG++L  +D     L
Sbjct  40   FLWWQHEEET---EDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVL  96

Query  85   AVLRAE----RAVNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE  137
            A  RA+    +AV   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE
Sbjct  97   AYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  156

Query  138  --------------NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERT  183
                           + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RT
Sbjct  157  LAHARAAVSQAQAAVKAALAEESSARA-ALGGQVSL-REQPAVQTAIGRLKDAWLNLQRT  214

Query  184  QVRAPVSGYVTNLQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VE  242
            Q+RAP  G V     + G    AG PL+A+V     +V   F+ET+L  + +G  A  V 
Sbjct  215  QIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVS  274

Query  243  LMSGER--FDGRVQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQ  300
             + G++  + GRV   +             L+   N +  W+K+ QR+PVRI ++     
Sbjct  275  DLYGKQIVYRGRVAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVD  329

Query  301  RNTLRAGVTATIRVLPAEDTAKVDSAAPGTAL  332
            R+ LR G++ T++V  +   A V S  PG AL
Sbjct  330  RHPLRIGLSMTVKVDTSAAGAPV-SKTPGAAL  360


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 95.9 bits (237),  Expect = 4e-22, Method: Compositional matrix adjust.
 Identities = 98/320 (31%), Positives = 153/320 (48%), Gaps = 32/320 (10%)

Query  37   TRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAE----RA  92
            T DA V   VV ++    G + ++   D   V+KG++L  +D     LA  RA+    +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  93   VNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE------------  137
            V   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE            
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  138  --NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTN  195
               + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RTQ+RAP  G V  
Sbjct  175  AAVKAALAEESSARA-ALGGQVSL-REQPEVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  232

Query  196  LQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELMSGER--FDGR  252
               + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  + G++  + GR
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  292

Query  253  VQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRNTLRAGVTATI  312
            V   +             L+   N +  W+K+ QR+PVRI ++     R+ LR G++ T+
Sbjct  293  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  347

Query  313  RVLPAEDTAKVDSAAPGTAL  332
            +V  +   A V S  PG AL
Sbjct  348  KVDTSAAGAPV-SKTPGAAL  366


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 95.5 bits (236),  Expect = 5e-22, Method: Compositional matrix adjust.
 Identities = 101/330 (31%), Positives = 158/330 (48%), Gaps = 31/330 (9%)

Query  25   FLAWERYTRTPWTRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYEL  84
            FL W+    T    DA V   VV ++    G + ++   D   V+KG++L  +D     L
Sbjct  46   FLWWQHEEET---EDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVL  102

Query  85   AVLRAE----RAVNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE  137
            A  RA+    +AV   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE
Sbjct  103  AYERAKNELIQAVRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  138  -------NEKAQTDVSLAQAELLRNQASLG-----LAQANVELAEAALQQARLDLERTQV  185
                     +AQ  V  A AE    +A+LG       Q  V+ A   L+ A L+L+RTQ+
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVALREQPAVQTAIGRLKDAWLNLQRTQI  222

Query  186  RAPVSGYVTNLQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELM  244
            RAP  G V     + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  +
Sbjct  223  RAPTDGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDL  282

Query  245  SGER--FDGRVQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRN  302
             G++  + G V   +             L+   N +  W+K+ QR+PVRI ++     R+
Sbjct  283  YGKQIVYRGMVAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRH  337

Query  303  TLRAGVTATIRVLPAEDTAKVDSAAPGTAL  332
             LR G++ T++V  +  +A V S  PG AL
Sbjct  338  PLRIGLSMTVKVDTSAASAPV-SKTPGAAL  366


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 95.1 bits (235),  Expect = 7e-22, Method: Compositional matrix adjust.
 Identities = 98/320 (31%), Positives = 153/320 (48%), Gaps = 32/320 (10%)

Query  37   TRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAE----RA  92
            T DA V   VV ++    G + ++   D   V+KG++L  +D     LA  RA+    +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  93   VNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE------------  137
            V   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  138  --NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTN  195
               + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RTQ+RAP  G V  
Sbjct  169  AAVKAALAEESSARA-ALGGQVSL-REQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  196  LQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELMSGER--FDGR  252
               + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  + G++  + GR
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  253  VQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRNTLRAGVTATI  312
            V   +             L+   N +  W+K+ QR+PVRI ++     R+ LR G++ T+
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  313  RVLPAEDTAKVDSAAPGTAL  332
            +V  +   A V S  PG AL
Sbjct  342  KVDTSAAGAPV-SKTPGAAL  360


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 94.7 bits (234),  Expect = 8e-22, Method: Compositional matrix adjust.
 Identities = 98/320 (31%), Positives = 153/320 (48%), Gaps = 32/320 (10%)

Query  37   TRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAE----RA  92
            T DA V   VV ++    G + ++   D   V+KG++L  +D     LA  RA+    +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  93   VNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE------------  137
            V   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  138  --NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTN  195
               + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RTQ+RAP  G V  
Sbjct  169  AAVKAALAEESSARA-ALGGQVSL-REQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  196  LQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELMSGER--FDGR  252
               + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  + G++  + GR
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  253  VQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRNTLRAGVTATI  312
            V   +             L+   N +  W+K+ QR+PVRI ++     R+ LR G++ T+
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  313  RVLPAEDTAKVDSAAPGTAL  332
            +V  +   A V S  PG AL
Sbjct  342  KVDTSAAGAPV-SKTPGAAL  360


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 94.7 bits (234),  Expect = 9e-22, Method: Compositional matrix adjust.
 Identities = 98/320 (31%), Positives = 153/320 (48%), Gaps = 32/320 (10%)

Query  37   TRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAE----RA  92
            T DA V   VV ++    G + ++   D   V+KG++L  +D     LA  RA+    +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  93   VNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE------------  137
            V   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  138  --NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTN  195
               + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RTQ+RAP  G V  
Sbjct  169  AAVKAALAEESSARA-ALGGQVSL-REQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  196  LQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELMSGER--FDGR  252
               + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  + G++  + GR
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  253  VQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRNTLRAGVTATI  312
            V   +             L+   N +  W+K+ QR+PVRI ++     R+ LR G++ T+
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  313  RVLPAEDTAKVDSAAPGTAL  332
            +V  +   A V S  PG AL
Sbjct  342  KVDTSAAGAPV-SKTPGAAL  360


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 94.7 bits (234),  Expect = 1e-21, Method: Compositional matrix adjust.
 Identities = 98/320 (31%), Positives = 153/320 (48%), Gaps = 32/320 (10%)

Query  37   TRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAE----RA  92
            T DA V   VV ++    G + ++   D   V+KG++L  +D     LA  RA+    +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  93   VNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE------------  137
            V   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE            
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  138  --NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTN  195
               + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RTQ+RAP  G V  
Sbjct  175  AAVKAALAEESSARA-ALGGQVSL-REQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  232

Query  196  LQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELMSGER--FDGR  252
               + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  + G++  + GR
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  292

Query  253  VQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRNTLRAGVTATI  312
            V   +             L+   N +  W+K+ QR+PVRI ++     R+ LR G++ T+
Sbjct  293  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  347

Query  313  RVLPAEDTAKVDSAAPGTAL  332
            +V  +   A V S  PG AL
Sbjct  348  KVDTSAAGAPV-SKTPGAAL  366


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 94.7 bits (234),  Expect = 1e-21, Method: Compositional matrix adjust.
 Identities = 98/320 (31%), Positives = 153/320 (48%), Gaps = 32/320 (10%)

Query  37   TRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAE----RA  92
            T DA V   VV ++    G + ++   D   V+KG++L  +D     LA  RA+    +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  93   VNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE------------  137
            V   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  138  --NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTN  195
               + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RTQ+RAP  G V  
Sbjct  169  AAVKAALAEESSARA-ALGGQVSL-REQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  196  LQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELMSGER--FDGR  252
               + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  + G++  + GR
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  253  VQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRNTLRAGVTATI  312
            V   +             L+   N +  W+K+ QR+PVRI ++     R+ LR G++ T+
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  313  RVLPAEDTAKVDSAAPGTAL  332
            +V  +   A V S  PG AL
Sbjct  342  KVDTSAAGAPV-SKTPGAAL  360


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 93.2 bits (230),  Expect = 3e-21, Method: Compositional matrix adjust.
 Identities = 97/320 (30%), Positives = 152/320 (48%), Gaps = 32/320 (10%)

Query  37   TRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAE----RA  92
            T DA V   VV ++    G + ++   D   V+KG++L  +D     LA  RA+    +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  93   VNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE------------  137
            V   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  138  --NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTN  195
               + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RTQ+R P  G V  
Sbjct  169  AAVKAALAEESSARA-ALGGQVSL-REQPAVQTAIGRLKDAWLNLQRTQIRTPADGQVAK  226

Query  196  LQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELMSGER--FDGR  252
               + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  + G++  + GR
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  253  VQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRNTLRAGVTATI  312
            V   +             L+   N +  W+K+ QR+PVRI ++     R+ LR G++ T+
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  313  RVLPAEDTAKVDSAAPGTAL  332
            +V  +   A V S  PG AL
Sbjct  342  KVDTSAAGAPV-SKTPGAAL  360


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 91.3 bits (225),  Expect = 9e-21, Method: Compositional matrix adjust.
 Identities = 80/326 (25%), Positives = 149/326 (46%), Gaps = 23/326 (7%)

Query  9    PRLATLLAVLVAAALVFLAWERYTRTPWTRDARVRADVVTLSADVSGLITRLPLSDNQPV  68
            P+    + +L+   L  L +      P+T +A V A+V  ++A+V G IT + + + Q V
Sbjct  5    PKAGFPVIILLCVFLFILIYHYSYLFPFTNNAFVVANVRPVAANVKGYITNIYVKNEQEV  64

Query  69   EKGELLLSIDPARYELAVLRAERAVNVARAALGESRAAIEASQAQLR-------------  115
            +KG+ L ++  A YELA  +A   V  A+A L      +E ++  L+             
Sbjct  65   KKGQPLFTVFKAPYELAYRKAVSHVQEAKAQLLLFNKQVEKTKYLLQAQKELYEKFRFDY  124

Query  116  QRRSEAQRRSALQKRSMLSV-EENEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQ  174
            +    A R  A+ K ++ ++ +E   A + +   + EL  NQ  + + +  ++   A ++
Sbjct  125  EHNYSASRDHAVSKLTVNTMLKEKNAALSKLKALEKELEVNQQQVIVQKKKIDSLIAVMK  184

Query  175  QARLDLERTQVRAPVSGYVTNLQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIH  234
             A++DL+ T V A  +G V ++    G       P+ A+ D D+ ++   F ET L  + 
Sbjct  185  NAKIDLDETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQANFNETDLRRVQ  244

Query  235  VGSRARV--ELMSGER-FDGRVQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVR  291
             G +  +   +  G + + G + S   A +  E    +++    N    W  L QR+PV+
Sbjct  245  PGDKVSIFPRMYFGSKIYHGVILSRNWAASRLETHRATQIQIVRNSESNWFLLPQRLPVQ  304

Query  292  IAI---DPAYRQRNTLRAGVTATIRV  314
            I I   DP +     L  G +A + +
Sbjct  305  IQITDYDPVHY---PLSIGASAYVYI  327


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 91.3 bits (225),  Expect = 2e-20, Method: Compositional matrix adjust.
 Identities = 97/320 (30%), Positives = 152/320 (48%), Gaps = 32/320 (10%)

Query  37   TRDARVRADVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAE----RA  92
            T DA V   VV ++    G + ++   D   V+KG++L  +D     LA  RA+    +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  93   VNVAR---AALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEE------------  137
            V   R   AA  ++ A +   +A L + + + +RRSAL +   +S EE            
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  138  --NEKAQTDVSLAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTN  195
               + A  + S A+A  L  Q SL   Q  V+ A   L+ A L+L+RTQ+RA   G V  
Sbjct  175  AAVKAALAEESSARA-ALGGQVSL-REQPAVQTAIGRLKDAWLNLQRTQIRASADGQVAK  232

Query  196  LQTREGDYAHAGVPLLALVDRDSFYVSGYFEETKLPGIHVGSRAR-VELMSGER--FDGR  252
               + G    AG PL+A+V     +V   F+ET+L  + +G  A  V  + G++  + GR
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  292

Query  253  VQSIAHAITDRENAEGSRLLANINPSYTWVKLAQRIPVRIAIDPAYRQRNTLRAGVTATI  312
            V   +             L+   N +  W+K+ QR+PVRI ++     R+ LR G++ T+
Sbjct  293  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  347

Query  313  RVLPAEDTAKVDSAAPGTAL  332
            +V  +   A V S  PG AL
Sbjct  348  KVDTSAAGAPV-SKTPGAAL  366


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 61.2 bits (147),  Expect = 2e-10, Method: Compositional matrix adjust.
 Identities = 52/181 (29%), Positives = 85/181 (47%), Gaps = 36/181 (20%)

Query  28   WERYTRTPWTRDARVRA-DVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAV  86
            W+ Y+        R+ A D V +   VSG +  +   D   V+KG+LL +IDP  +E   
Sbjct  59   WQEYS-------GRLEAIDQVDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDPRPFE---  108

Query  87   LRAERAVNVARAALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEENEKAQTDVS  146
                       A L  ++A + +++AQ+    S   R   L + + +S +E + A+ D  
Sbjct  109  -----------AELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDAR  157

Query  147  LAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTNLQTREGDYAHA  206
             A A              N++ A AA+Q ARL+LE T++ APVSG ++  +   G+   A
Sbjct  158  SANA--------------NLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSA  203

Query  207  G  207
            G
Sbjct  204  G  204


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 61.2 bits (147),  Expect = 2e-10, Method: Compositional matrix adjust.
 Identities = 52/181 (29%), Positives = 85/181 (47%), Gaps = 36/181 (20%)

Query  28   WERYTRTPWTRDARVRA-DVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAV  86
            W+ Y+        R+ A D V +   VSG +  +   D   V+KG+LL +IDP  +E   
Sbjct  59   WQEYS-------GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFE---  108

Query  87   LRAERAVNVARAALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEENEKAQTDVS  146
                       A L  ++A + +++AQ+    S   R   L + + +S +E + A+ D  
Sbjct  109  -----------AELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDAR  157

Query  147  LAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTNLQTREGDYAHA  206
             A A              N++ A AA+Q ARL+LE T++ APVSG ++  +   G+   A
Sbjct  158  SANA--------------NLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSA  203

Query  207  G  207
            G
Sbjct  204  G  204


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 61.2 bits (147),  Expect = 2e-10, Method: Compositional matrix adjust.
 Identities = 52/181 (29%), Positives = 85/181 (47%), Gaps = 36/181 (20%)

Query  28   WERYTRTPWTRDARVRA-DVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAV  86
            W+ Y+        R+ A D V +   VSG +  +   D   V+KG+LL +IDP  +E   
Sbjct  59   WQEYS-------GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFE---  108

Query  87   LRAERAVNVARAALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEENEKAQTDVS  146
                       A L  ++A + +++AQ+    S   R   L + + +S +E + A+ D  
Sbjct  109  -----------AELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDAR  157

Query  147  LAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTNLQTREGDYAHA  206
             A A              N++ A AA+Q ARL+LE T++ APVSG ++  +   G+   A
Sbjct  158  SANA--------------NLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSA  203

Query  207  G  207
            G
Sbjct  204  G  204


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 61.2 bits (147),  Expect = 2e-10, Method: Compositional matrix adjust.
 Identities = 52/181 (29%), Positives = 85/181 (47%), Gaps = 36/181 (20%)

Query  28   WERYTRTPWTRDARVRA-DVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAV  86
            W+ Y+        R+ A D V +   VSG +  +   D   V+KG+LL +IDP  +E   
Sbjct  59   WQEYS-------GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFE---  108

Query  87   LRAERAVNVARAALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEENEKAQTDVS  146
                       A L  ++A + +++AQ+    S   R   L + + +S +E + A+ D  
Sbjct  109  -----------AELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDAR  157

Query  147  LAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTNLQTREGDYAHA  206
             A A              N++ A AA+Q ARL+LE T++ APVSG ++  +   G+   A
Sbjct  158  SANA--------------NLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSA  203

Query  207  G  207
            G
Sbjct  204  G  204


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 60.8 bits (146),  Expect = 3e-10, Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (46%), Gaps = 39/204 (19%)

Query  28   WERYTRTPWTRDARVRA-DVVTLSADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAV  86
            W+ Y+        R+ A D V +   VSG +  +   D   V+KG+LL +IDP  +E   
Sbjct  35   WQEYS-------GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFE---  84

Query  87   LRAERAVNVARAALGESRAAIEASQAQLRQRRSEAQRRSALQKRSMLSVEENEKAQTDVS  146
                       A L  ++A + +++AQ+    S   R   L + + +S +E + A+ D  
Sbjct  85   -----------AELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDAR  133

Query  147  LAQAELLRNQASLGLAQANVELAEAALQQARLDLERTQVRAPVSGYVTNLQTREGDYAHA  206
             A A              N++ A AA+Q ARL+LE T++ APVSG ++  +   G+   A
Sbjct  134  SANA--------------NLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSA  179

Query  207  GVP---LLALVDRDSFYVSGYFEE  227
            G     L +LV     Y S   +E
Sbjct  180  GNGAQVLTSLVSVSRLYASFDVDE  203


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 47.0 bits (110),  Expect = 9e-06, Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 28/157 (18%)

Query  51   ADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAERAVNVARAALGESRAAIEAS  110
            A V G+I +    +   V  G+ L  ID + YE              A L  +RA +  +
Sbjct  77   AQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE--------------AGLESARAQLATA  122

Query  111  QAQLRQRRSEAQRRSALQKRSMLSVEENEKAQTDVSLAQAELLRNQASLGLAQANVELAE  170
            QA L +  ++  R   L     +S +E + A T              +   A+A V+ A+
Sbjct  123  QATLAKADADLARYKPLVSADAISKQEYDAAVT--------------AKRSAEAGVKAAQ  168

Query  171  AALQQARLDLERTQVRAPVSGYVTNLQTREGDYAHAG  207
            AA++ A ++L R+++ AP+SG++   +  EG   +AG
Sbjct  169  AAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAG  205


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 47.0 bits (110),  Expect = 1e-05, Method: Compositional matrix adjust.
 Identities = 42/157 (27%), Positives = 72/157 (46%), Gaps = 28/157 (18%)

Query  51   ADVSGLITRLPLSDNQPVEKGELLLSIDPARYELAVLRAERAVNVARAALGESRAAIEAS  110
            A V G+I +    +   V  G+ L  ID + YE              A L  +RA +  +
Sbjct  77   AQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE--------------AGLESARAQLATA  122

Query  111  QAQLRQRRSEAQRRSALQKRSMLSVEENEKAQTDVSLAQAELLRNQASLGLAQANVELAE  170
            QA L +  ++  R   L     +S +E + A T          R+      A+A V+ A+
Sbjct  123  QATLAKADADLARYKPLVSADAISKQEYDAAVT--------AKRS------AEAGVKAAQ  168

Query  171  AALQQARLDLERTQVRAPVSGYVTNLQTREGDYAHAG  207
            AA++ A ++L R+++ AP+SG++   +  EG   +AG
Sbjct  169  AAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAG  205



Lambda      K        H        a         alpha
   0.317    0.130    0.357    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2440022833


Query= g3368.t1

Length=285
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  84.7    1e-18
VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  84.3    2e-18
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  83.2    5e-18
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  82.8    7e-18
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  82.4    9e-18
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  82.0    1e-17
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  81.6    1e-17
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  81.3    1e-17
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  81.6    1e-17
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  81.6    2e-17
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  81.6    2e-17
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  81.3    2e-17
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  79.7    6e-17
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  61.6    1e-10
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  61.2    1e-10
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  61.2    1e-10
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  60.5    2e-10
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  60.5    2e-10


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 84.7 bits (208),  Expect = 1e-18, Method: Compositional matrix adjust.
 Identities = 93/300 (31%), Positives = 137/300 (46%), Gaps = 56/300 (19%)

Query  34   TRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQER-----YQANLEQARA  88
            T DA V   VV V P   G V  +   D   VK GDVL  +D +       +A  E  +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  89   VAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED------------  119
            V + R Q         Q  LR       Q++  RRS L   GA+SAE+            
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  120  -------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSELRAARNGQVTNLR  165
                    E +   AA+        + E Q A+ ++K A LNL+R+++RA  +GQV    
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  234

Query  166  LAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLMSGDQPI-DGTVE  223
            +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  + G Q +  G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  294

Query  224  SISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH-LSAGMTASVTV  282
              S+G     S     L+     T NW+++ QR+PVRI L++   D H L  G++ +V V
Sbjct  295  GFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  349


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 84.3 bits (207),  Expect = 2e-18, Method: Compositional matrix adjust.
 Identities = 93/300 (31%), Positives = 137/300 (46%), Gaps = 56/300 (19%)

Query  34   TRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQER-----YQANLEQARA  88
            T DA V   VV V P   G V  +   D   VK GDVL  +D +       +A  E  +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  89   VAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED------------  119
            V + R Q         Q  LR       Q++  RRS L   GA+SAE+            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARTAVSQAQ  168

Query  120  -------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSELRAARNGQVTNLR  165
                    E +   AA+        + E Q A+ ++K A LNL+R+++RA  +GQV    
Sbjct  169  AAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQVAKRS  228

Query  166  LAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLMSGDQPI-DGTVE  223
            +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  + G Q +  G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  224  SISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH-LSAGMTASVTV  282
              S+G     S     L+     T NW+++ QR+PVRI L++   D H L  G++ +V V
Sbjct  289  GFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  343


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 83.2 bits (204),  Expect = 5e-18, Method: Compositional matrix adjust.
 Identities = 94/312 (30%), Positives = 140/312 (45%), Gaps = 58/312 (19%)

Query  22   IWLWRYYMLSPWTRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQERYQA  81
             +LW  +     T DA V   VV V P   G V  +   D   VK GDVL  +D +    
Sbjct  45   FFLW--WQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVL  102

Query  82   NLEQAR-----AVAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED  119
              E+A+     AV + R Q         Q  LR       Q++  RRS L   GA+SAE+
Sbjct  103  AYERAKNELIQAVRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  120  -------------------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSEL  153
                                E +   AA+        +   Q A+ ++K A LNL+R+++
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVALREQPAVQTAIGRLKDAWLNLQRTQI  222

Query  154  RAARNGQVTNLRLAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLM  212
            RA  +GQV    +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  +
Sbjct  223  RAPTDGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDL  282

Query  213  SGDQPI-DGTVESISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH  271
             G Q +  G V   S+G     S     L+     T NW+++ QR+PVRI L++   D H
Sbjct  283  YGKQIVYRGMVAGFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRH  337

Query  272  -LSAGMTASVTV  282
             L  G++ +V V
Sbjct  338  PLRIGLSMTVKV  349


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 82.8 bits (203),  Expect = 7e-18, Method: Compositional matrix adjust.
 Identities = 94/312 (30%), Positives = 140/312 (45%), Gaps = 58/312 (19%)

Query  22   IWLWRYYMLSPWTRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQER---  78
             +LW  +     T DA V   VV V P   G V  +   D   VK GDVL  +D +    
Sbjct  39   FFLW--WQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVL  96

Query  79   --YQANLEQARAVAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED  119
               +A  E  +AV + R Q         Q  LR       Q++  RRS L   GA+SAE+
Sbjct  97   AYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  156

Query  120  -------------------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSEL  153
                                E +   AA+        +   Q A+ ++K A LNL+R+++
Sbjct  157  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQI  216

Query  154  RAARNGQVTNLRLAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLM  212
            RA  +GQV    +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  +
Sbjct  217  RAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDL  276

Query  213  SGDQPI-DGTVESISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH  271
             G Q +  G V   S+G     S     L+     T NW+++ QR+PVRI L++   D H
Sbjct  277  YGKQIVYRGRVAGFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRH  331

Query  272  -LSAGMTASVTV  282
             L  G++ +V V
Sbjct  332  PLRIGLSMTVKV  343


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 82.4 bits (202),  Expect = 9e-18, Method: Compositional matrix adjust.
 Identities = 94/312 (30%), Positives = 140/312 (45%), Gaps = 58/312 (19%)

Query  22   IWLWRYYMLSPWTRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQERYQA  81
             +LW  +     T DA V   VV V P   G V  +   D   VK GDVL  +D +    
Sbjct  45   FFLW--WQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVL  102

Query  82   NLEQAR-----AVAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED  119
              E+A+     AV + R Q         Q  LR       Q++  RRS L   GA+SAE+
Sbjct  103  AYERAKNELIQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  120  -------------------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSEL  153
                                E +   AA+        +   Q A+ ++K A LNL+R+++
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQI  222

Query  154  RAARNGQVTNLRLAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLM  212
            RA  +GQV    +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  +
Sbjct  223  RAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDL  282

Query  213  SGDQPI-DGTVESISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH  271
             G Q +  G V   S+G     S     L+     T NW+++ QR+PVRI L++   D H
Sbjct  283  YGKQIVYRGRVAGFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRH  337

Query  272  -LSAGMTASVTV  282
             L  G++ +V V
Sbjct  338  PLRIGLSMTVKV  349


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 82.0 bits (201),  Expect = 1e-17, Method: Compositional matrix adjust.
 Identities = 92/300 (31%), Positives = 137/300 (46%), Gaps = 56/300 (19%)

Query  34   TRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQER-----YQANLEQARA  88
            T DA V   VV V P   G V  +   D   VK GDVL  +D +       +A  E  +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  89   VAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED------------  119
            V + R Q         Q  LR       Q++  RRS L   GA+SAE+            
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  120  -------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSELRAARNGQVTNLR  165
                    E +   AA+        +   Q A+ ++K A LNL+R+++RA+ +GQV    
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRASADGQVAKRS  234

Query  166  LAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLMSGDQPI-DGTVE  223
            +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  + G Q +  G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  294

Query  224  SISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH-LSAGMTASVTV  282
              S+G     S     L+     T NW+++ QR+PVRI L++   D H L  G++ +V V
Sbjct  295  GFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  349


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 81.6 bits (200),  Expect = 1e-17, Method: Compositional matrix adjust.
 Identities = 92/300 (31%), Positives = 136/300 (45%), Gaps = 56/300 (19%)

Query  34   TRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQERYQANLEQAR-----A  88
            T DA V   VV V P   G V  +   D   VK GDVL  +D +      E+A+     A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  89   VAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED------------  119
            V + R Q         Q  LR       Q++  RRS L   GA+SAE+            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  120  -------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSELRAARNGQVTNLR  165
                    E +   AA+        +   Q A+ ++K A LNL+R+++RA  +GQV    
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  166  LAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLMSGDQPI-DGTVE  223
            +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  + G Q +  G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  224  SISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH-LSAGMTASVTV  282
              S+G     S     L+     T NW+++ QR+PVRI L++   D H L  G++ +V V
Sbjct  289  GFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  343


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 81.3 bits (199),  Expect = 1e-17, Method: Compositional matrix adjust.
 Identities = 81/323 (25%), Positives = 146/323 (45%), Gaps = 56/323 (17%)

Query  12   LVVAAAVLAGIWLWRYYMLSPWTRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVL  71
            +++   V   I ++ Y  L P+T +A V A+V  VA +V G++T++ VK+ Q VK G  L
Sbjct  11   VIILLCVFLFILIYHYSYLFPFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKKGQPL  70

Query  72   MRIDQERYQ-------ANLEQARAV-----AETRHQQYLLR--------------QNEAA  105
              + +  Y+       +++++A+A       +    +YLL+               N +A
Sbjct  71   FTVFKAPYELAYRKAVSHVQEAKAQLLLFNKQVEKTKYLLQAQKELYEKFRFDYEHNYSA  130

Query  106  RR----SRLGIGAISAEDK-------------ENAQINAAIARSEYQEALAQVKIAELNL  148
             R    S+L +  +  E               E  Q    + + +    +A +K A+++L
Sbjct  131  SRDHAVSKLTVNTMLKEKNAALSKLKALEKELEVNQQQVIVQKKKIDSLIAVMKNAKIDL  190

Query  149  KRSELRAARNGQVTNLRLAQGNYATAGQAVMALVDQQSFYVVAYFEETKL----PGIRVG  204
              + + A +NG V ++ +A G      + V A+ D  + ++ A F ET L    PG +V 
Sbjct  191  DETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQANFNETDLRRVQPGDKVS  250

Query  205  MRAQVRLMSGDQPIDGTVES---ISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRI  261
            +    R+  G +   G + S    +S +    +T   Q++ N E   NW  L QR+PV+I
Sbjct  251  IFP--RMYFGSKIYHGVILSRNWAASRLETHRAT-QIQIVRNSES--NWFLLPQRLPVQI  305

Query  262  RL-DQVPADVHLSAGMTASVTVQ  283
            ++ D  P    LS G +A V + 
Sbjct  306  QITDYDPVHYPLSIGASAYVYIH  328


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 81.6 bits (200),  Expect = 1e-17, Method: Compositional matrix adjust.
 Identities = 92/300 (31%), Positives = 136/300 (45%), Gaps = 56/300 (19%)

Query  34   TRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQER-----YQANLEQARA  88
            T DA V   VV V P   G V  +   D   VK GDVL  +D +       +A  E  +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  89   VAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED------------  119
            V + R Q         Q  LR       Q++  RRS L   GA+SAE+            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  120  -------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSELRAARNGQVTNLR  165
                    E +   AA+        +   Q A+ ++K A LNL+R+++RA  +GQV    
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  166  LAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLMSGDQPI-DGTVE  223
            +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  + G Q +  G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  224  SISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH-LSAGMTASVTV  282
              S+G     S     L+     T NW+++ QR+PVRI L++   D H L  G++ +V V
Sbjct  289  GFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  343


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 81.6 bits (200),  Expect = 2e-17, Method: Compositional matrix adjust.
 Identities = 92/300 (31%), Positives = 136/300 (45%), Gaps = 56/300 (19%)

Query  34   TRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQERYQANLEQAR-----A  88
            T DA V   VV V P   G V  +   D   VK GDVL  +D +      E+A+     A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  89   VAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED------------  119
            V + R Q         Q  LR       Q++  RRS L   GA+SAE+            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  120  -------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSELRAARNGQVTNLR  165
                    E +   AA+        +   Q A+ ++K A LNL+R+++RA  +GQV    
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  166  LAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLMSGDQPI-DGTVE  223
            +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  + G Q +  G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  224  SISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH-LSAGMTASVTV  282
              S+G     S     L+     T NW+++ QR+PVRI L++   D H L  G++ +V V
Sbjct  289  GFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  343


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 81.6 bits (200),  Expect = 2e-17, Method: Compositional matrix adjust.
 Identities = 92/300 (31%), Positives = 136/300 (45%), Gaps = 56/300 (19%)

Query  34   TRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQERYQANLEQAR-----A  88
            T DA V   VV V P   G V  +   D   VK GDVL  +D +      E+A+     A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  89   VAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED------------  119
            V + R Q         Q  LR       Q++  RRS L   GA+SAE+            
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  120  -------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSELRAARNGQVTNLR  165
                    E +   AA+        +   Q A+ ++K A LNL+R+++RA  +GQV    
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  234

Query  166  LAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLMSGDQPI-DGTVE  223
            +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  + G Q +  G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  294

Query  224  SISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH-LSAGMTASVTV  282
              S+G     S     L+     T NW+++ QR+PVRI L++   D H L  G++ +V V
Sbjct  295  GFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  349


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 81.3 bits (199),  Expect = 2e-17, Method: Compositional matrix adjust.
 Identities = 92/300 (31%), Positives = 136/300 (45%), Gaps = 56/300 (19%)

Query  34   TRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQER-----YQANLEQARA  88
            T DA V   VV V P   G V  +   D   VK GDVL  +D +       +A  E  +A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  89   VAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED------------  119
            V + R Q         Q  LR       Q++  RRS L   GA+SAE+            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  120  -------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSELRAARNGQVTNLR  165
                    E +   AA+        +   Q A+ ++K A LNL+R+++RA  +GQV    
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  166  LAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLMSGDQPI-DGTVE  223
            +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  + G Q +  G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  224  SISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH-LSAGMTASVTV  282
              S+G     S     L+     T NW+++ QR+PVRI L++   D H L  G++ +V V
Sbjct  289  GFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  343


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 79.7 bits (195),  Expect = 6e-17, Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 135/300 (45%), Gaps = 56/300 (19%)

Query  34   TRDARVRADVVVVAPDVSGWVTDLEVKDNQVVKVGDVLMRIDQERYQANLEQAR-----A  88
            T DA V   VV V P   G V  +   D   VK GDVL  +D +      E+A+     A
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  89   VAETRHQ---------QYLLR-------QNEAARRSRLG-IGAISAED------------  119
            V + R Q         Q  LR       Q++  RRS L   GA+SAE+            
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  120  -------KENAQINAAIA-------RSEYQEALAQVKIAELNLKRSELRAARNGQVTNLR  165
                    E +   AA+        +   Q A+ ++K A LNL+R+++R   +GQV    
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRTPADGQVAKRS  228

Query  166  LAQGNYATAGQAVMALVDQQSFYVVAYFEETKLPGIRVGMRAQ-VRLMSGDQPI-DGTVE  223
            +  G    AG  +MA+V     +V A F+ET+L  +++G  A+ V  + G Q +  G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  224  SISSGITDRNSTPDGQLLANVEPTFNWVRLAQRIPVRIRLDQVPADVH-LSAGMTASVTV  282
              S+G     S     L+     T NW+++ QR+PVRI L++   D H L  G++ +V V
Sbjct  289  GFSAGTGSAFS-----LIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  343


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 61.6 bits (148),  Expect = 1e-10, Method: Compositional matrix adjust.
 Identities = 66/255 (26%), Positives = 114/255 (45%), Gaps = 40/255 (16%)

Query  14   VAAAVLAGIWLWRYYMLSPWTRDARVRA-DVVVVAPDVSGWVTDLEVKDNQVVKVGDVLM  72
            VA  V   I  W+ Y         R+ A D V + P VSG +  +  KD  +VK GD+L 
Sbjct  48   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLVAVHFKDGSLVKKGDLLF  100

Query  73   RIDQERYQANLEQARAVAETRHQQYLLRQNEAARRSRL-GIGAISAEDKENAQINAAIAR  131
             ID   ++A L +A+A   +   Q     +  +R  RL    A+S ++ + A+ +A  A 
Sbjct  101  TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  160

Query  132  SEYQEALAQVKIAELNLKRSELRAARNGQVTNLRLAQGNYATAGQAVMAL----------  181
            +  Q A A V+ A LNL+ + + A  +G+++   +  GN  +AG     L          
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  220

Query  182  ----VDQQSF--YVVAYFEETKLPGIRVGMRAQVRLMSGDQPIDGTVESISSGITDRNST  235
                VD+Q++  Y+      +++P + +G+  +          +GT+ SI + +   + T
Sbjct  221  ASFDVDEQTYLKYISNQRNSSQVP-VYMGLANETGFTR-----EGTINSIDNNLNTTSGT  274

Query  236  ---------PDGQLL  241
                     P+G LL
Sbjct  275  IRVRATFDNPNGVLL  289


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 61.2 bits (147),  Expect = 1e-10, Method: Compositional matrix adjust.
 Identities = 66/255 (26%), Positives = 114/255 (45%), Gaps = 40/255 (16%)

Query  14   VAAAVLAGIWLWRYYMLSPWTRDARVRA-DVVVVAPDVSGWVTDLEVKDNQVVKVGDVLM  72
            VA  V   I  W+ Y         R+ A D V + P VSG +  +  KD  +VK GD+L 
Sbjct  48   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLF  100

Query  73   RIDQERYQANLEQARAVAETRHQQYLLRQNEAARRSRL-GIGAISAEDKENAQINAAIAR  131
             ID   ++A L +A+A   +   Q     +  +R  RL    A+S ++ + A+ +A  A 
Sbjct  101  TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  160

Query  132  SEYQEALAQVKIAELNLKRSELRAARNGQVTNLRLAQGNYATAGQAVMAL----------  181
            +  Q A A V+ A LNL+ + + A  +G+++   +  GN  +AG     L          
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  220

Query  182  ----VDQQSF--YVVAYFEETKLPGIRVGMRAQVRLMSGDQPIDGTVESISSGITDRNST  235
                VD+Q++  Y+      +++P + +G+  +          +GT+ SI + +   + T
Sbjct  221  ASFDVDEQTYLKYISNQRNSSQVP-VYMGLANETGFTR-----EGTINSIDNNLNTTSGT  274

Query  236  ---------PDGQLL  241
                     P+G LL
Sbjct  275  IRVRATFDNPNGVLL  289


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 61.2 bits (147),  Expect = 1e-10, Method: Compositional matrix adjust.
 Identities = 66/255 (26%), Positives = 114/255 (45%), Gaps = 40/255 (16%)

Query  14   VAAAVLAGIWLWRYYMLSPWTRDARVRA-DVVVVAPDVSGWVTDLEVKDNQVVKVGDVLM  72
            VA  V   I  W+ Y         R+ A D V + P VSG +  +  KD  +VK GD+L 
Sbjct  48   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLF  100

Query  73   RIDQERYQANLEQARAVAETRHQQYLLRQNEAARRSRL-GIGAISAEDKENAQINAAIAR  131
             ID   ++A L +A+A   +   Q     +  +R  RL    A+S ++ + A+ +A  A 
Sbjct  101  TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  160

Query  132  SEYQEALAQVKIAELNLKRSELRAARNGQVTNLRLAQGNYATAGQAVMAL----------  181
            +  Q A A V+ A LNL+ + + A  +G+++   +  GN  +AG     L          
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  220

Query  182  ----VDQQSF--YVVAYFEETKLPGIRVGMRAQVRLMSGDQPIDGTVESISSGITDRNST  235
                VD+Q++  Y+      +++P + +G+  +          +GT+ SI + +   + T
Sbjct  221  ASFDVDEQTYLKYISNQRNSSQVP-VYMGLANETGFTR-----EGTINSIDNNLNTTSGT  274

Query  236  ---------PDGQLL  241
                     P+G LL
Sbjct  275  IRVRATFDNPNGVLL  289


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 60.5 bits (145),  Expect = 2e-10, Method: Compositional matrix adjust.
 Identities = 66/255 (26%), Positives = 113/255 (44%), Gaps = 40/255 (16%)

Query  14   VAAAVLAGIWLWRYYMLSPWTRDARVRA-DVVVVAPDVSGWVTDLEVKDNQVVKVGDVLM  72
            VA  V   I  W+ Y         R+ A D V + P VSG +  +  KD  +VK GD+L 
Sbjct  48   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLF  100

Query  73   RIDQERYQANLEQARAVAETRHQQYLLRQNEAARRSRL-GIGAISAEDKENAQINAAIAR  131
             ID   ++A L +A+A   +   Q     +  +R  RL    A+S ++ + A+ +A  A 
Sbjct  101  TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  160

Query  132  SEYQEALAQVKIAELNLKRSELRAARNGQVTNLRLAQGNYATAGQAVMAL----------  181
            +  Q A A V+ A LNL+ + + A  +G+++   +  GN  +AG     L          
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  220

Query  182  ----VDQQSF--YVVAYFEETKLPGIRVGMRAQVRLMSGDQPIDGTVESISSGITDRNST  235
                VD+Q++  Y+       ++P + +G+  +          +GT+ SI + +   + T
Sbjct  221  ASFDVDEQTYLKYISNQRNSAQVP-VYMGLANETGFTR-----EGTINSIDNNLNTTSGT  274

Query  236  ---------PDGQLL  241
                     P+G LL
Sbjct  275  IRVRATFDNPNGVLL  289


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 60.5 bits (145),  Expect = 2e-10, Method: Compositional matrix adjust.
 Identities = 66/255 (26%), Positives = 113/255 (44%), Gaps = 40/255 (16%)

Query  14   VAAAVLAGIWLWRYYMLSPWTRDARVRA-DVVVVAPDVSGWVTDLEVKDNQVVKVGDVLM  72
            VA  V   I  W+ Y         R+ A D V + P VSG +  +  KD  +VK GD+L 
Sbjct  24   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLF  76

Query  73   RIDQERYQANLEQARAVAETRHQQYLLRQNEAARRSRL-GIGAISAEDKENAQINAAIAR  131
             ID   ++A L +A+A   +   Q     +  +R  RL    A+S ++ + A+ +A  A 
Sbjct  77   TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  136

Query  132  SEYQEALAQVKIAELNLKRSELRAARNGQVTNLRLAQGNYATAGQAVMAL----------  181
            +  Q A A V+ A LNL+ + + A  +G+++   +  GN  +AG     L          
Sbjct  137  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  196

Query  182  ----VDQQSF--YVVAYFEETKLPGIRVGMRAQVRLMSGDQPIDGTVESISSGITDRNST  235
                VD+Q++  Y+       ++P + +G+  +          +GT+ SI + +   + T
Sbjct  197  ASFDVDEQTYLKYISNQRNSAQVP-VYMGLANETGFTR-----EGTINSIDNNLNTTSGT  250

Query  236  ---------PDGQLL  241
                     P+G LL
Sbjct  251  IRVRATFDNPNGVLL  265



Lambda      K        H        a         alpha
   0.319    0.131    0.367    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 1958238690


Query= g3426.t1

Length=352
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  75.5    4e-15
VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  68.6    9e-13
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  68.2    1e-12
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  68.2    1e-12
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  67.8    2e-12
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  67.8    2e-12
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  67.4    2e-12
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  67.4    2e-12
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  67.4    2e-12
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  67.4    2e-12
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  67.4    2e-12
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  67.0    3e-12
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  66.2    6e-12
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  53.5    7e-08
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  53.5    9e-08
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  53.5    9e-08
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  53.5    9e-08
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  53.1    1e-07


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 75.5 bits (184),  Expect = 4e-15, Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 8/258 (3%)

Query  13   VAIAVFVLLFVYFLVADLWMPLTPQAQLTRPVVRVAPRVSGQVAEVLVSNNGHVQPGEVL  72
            V I + V LF+         P T  A +   V  VA  V G +  + V N   V+ G+ L
Sbjct  11   VIILLCVFLFILIYHYSYLFPFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKKGQPL  70

Query  73   FRLDPEPFRLAVRQAELALEEAERTNRELDAAIASAKADLLAARSSAGELDSEARRTAQL  132
            F +   P+ LA R+A   ++EA+      +  +   K  L A +    +   +       
Sbjct  71   FTVFKAPYELAYRKAVSHVQEAKAQLLLFNKQVEKTKYLLQAQKELYEKFRFDYEHNYSA  130

Query  133  VQRHHVSQQMHEQVSAQAQAARARVAAAQARIGELTARRGTAGEDNLRLRQARNALAQAR  192
             + H VS+     +  +  AA +++ A +    EL   +        ++      +  A+
Sbjct  131  SRDHAVSKLTVNTMLKEKNAALSKLKALE---KELEVNQQQVIVQKKKIDSLIAVMKNAK  187

Query  193  LQLQYSSVRADRAGTLSNLQLTPGTYVPAGTPVAALVD-DRIDIVADFREKSLRYVRPGD  251
            + L  ++V A + G + ++ +  GT +    PV A+ D D + I A+F E  LR V+PGD
Sbjct  188  IDLDETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQANFNETDLRRVQPGD  247

Query  252  RAAVVFDARPGEVFGARV  269
            + ++     P   FG+++
Sbjct  248  KVSIF----PRMYFGSKI  261


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 68.6 bits (166),  Expect = 9e-13, Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 16/275 (6%)

Query  44   VVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDA  103
            VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A R NR  +A
Sbjct  58   VVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNA  117

Query  104  AIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQAR  163
            A + A A +   R+       + RR + L +   VS +  E   A+   ++A+ A   A 
Sbjct  118  ATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARTAVSQAQAAVKAAL  175

Query  164  IGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYV  219
              E +AR    G+ +LR    ++ A   L  A L L+ + VRA   G ++   +  G  V
Sbjct  176  AEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQVAKRSVQVGQQV  235

Query  220  PAGTPVAALV---DDRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFGARVAAIDAG  275
             AG P+ A+V   D  +D  A+F+E  LR+++ G  A +V D    + V+  RVA   AG
Sbjct  236  AAGAPLMAVVPLSDVWVD--ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAG  293

Query  276  VKEGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
                   A   + A   +  W++  QR  + +VL+
Sbjct  294  TGS----AFSLIPAQNATGNWIKVVQRVPVRIVLN  324


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 68.2 bits (165),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 137/284 (48%), Gaps = 16/284 (6%)

Query  35   TPQAQLTRPVVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEA  94
            T  A +   VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  95   ERTNRELDAAIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAAR  154
             R NR  +AA + A A +   R+       + RR + L +   VS +  E   A+A  ++
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  172

Query  155  ARVAAAQARIGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSN  210
            A+ A   A   E +AR    G+ +LR    ++ A   L  A L LQ + +RA   G ++ 
Sbjct  173  AQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRASADGQVAK  232

Query  211  LQLTPGTYVPAGTPVAALV---DDRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFG  266
              +  G  V AG P+ A+V   D  +D  A+F+E  LR+++ G  A +V D    + V+ 
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDVWVD--ANFKETQLRHMKIGQPAELVSDLYGKQIVYR  290

Query  267  ARVAAIDAGVKEGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
             RVA   AG       A   + A   +  W++  QR  + +VL+
Sbjct  291  GRVAGFSAGTGS----AFSLIPAQNATGNWIKVVQRVPVRIVLN  330


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 68.2 bits (165),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 133/273 (49%), Gaps = 12/273 (4%)

Query  44   VVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDA  103
            VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A R NR  +A
Sbjct  58   VVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNA  117

Query  104  AIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQAR  163
            A + A A +   R+       + RR + L +   VS +  E   A+A  ++A+ A   A 
Sbjct  118  ATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQAQAAVKAAL  175

Query  164  IGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYV  219
              E +AR    G+ +LR    ++ A   L  A L LQ + +RA   G ++   +  G  V
Sbjct  176  AEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQV  235

Query  220  PAGTPVAALVD-DRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFGARVAAIDAGVK  277
             AG P+ A+V    + + A+F+E  LR+++ G  A +V D    + V+  RVA   AG  
Sbjct  236  AAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTG  295

Query  278  EGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
                 A   + A   +  W++  QR  + +VL+
Sbjct  296  S----AFSLIPAQNATGNWIKVVQRVPVRIVLN  324


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 67.8 bits (164),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 133/273 (49%), Gaps = 12/273 (4%)

Query  44   VVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDA  103
            VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A R NR  +A
Sbjct  58   VVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNA  117

Query  104  AIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQAR  163
            A + A A +   R+       + RR + L +   VS +  E   A+A  ++A+ A   A 
Sbjct  118  ATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQAQAAVKAAL  175

Query  164  IGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYV  219
              E +AR    G+ +LR    ++ A   L  A L LQ + +RA   G ++   +  G  V
Sbjct  176  AEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQV  235

Query  220  PAGTPVAALVD-DRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFGARVAAIDAGVK  277
             AG P+ A+V    + + A+F+E  LR+++ G  A +V D    + V+  RVA   AG  
Sbjct  236  AAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTG  295

Query  278  EGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
                 A   + A   +  W++  QR  + +VL+
Sbjct  296  S----AFSLIPAQNATGNWIKVVQRVPVRIVLN  324


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 67.8 bits (164),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 84/275 (31%), Positives = 134/275 (49%), Gaps = 16/275 (6%)

Query  44   VVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDA  103
            VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A R NR  +A
Sbjct  58   VVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRRQNA  117

Query  104  AIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQAR  163
            A + A A +   R+       + RR + L +   VS +  E   A+A  ++A+ A   A 
Sbjct  118  ATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQAQAAVKAAL  175

Query  164  IGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYV  219
              E +AR    G+ +LR    ++ A   L  A L LQ + +RA   G ++   +  G  V
Sbjct  176  AEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQV  235

Query  220  PAGTPVAALV---DDRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFGARVAAIDAG  275
             AG P+ A+V   D  +D  A+F+E  LR+++ G  A +V D    + V+  RVA   AG
Sbjct  236  AAGAPLMAVVPLSDVWVD--ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAG  293

Query  276  VKEGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
                   A   + A   +  W++  QR  + +VL+
Sbjct  294  TGS----AFSLIPAQNATGNWIKVVQRVPVRIVLN  324


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 67.4 bits (163),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 133/273 (49%), Gaps = 12/273 (4%)

Query  44   VVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDA  103
            VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A R NR  +A
Sbjct  58   VVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNA  117

Query  104  AIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQAR  163
            A + A A +   R+       + RR + L +   VS +  E   A+A  ++A+ A   A 
Sbjct  118  ATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQAQAAVKAAL  175

Query  164  IGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYV  219
              E +AR    G+ +LR    ++ A   L  A L LQ + +RA   G ++   +  G  V
Sbjct  176  AEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQV  235

Query  220  PAGTPVAALVD-DRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFGARVAAIDAGVK  277
             AG P+ A+V    + + A+F+E  LR+++ G  A +V D    + V+  RVA   AG  
Sbjct  236  AAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTG  295

Query  278  EGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
                 A   + A   +  W++  QR  + +VL+
Sbjct  296  S----AFSLIPAQNATGNWIKVVQRVPVRIVLN  324


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 67.4 bits (163),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 133/273 (49%), Gaps = 12/273 (4%)

Query  44   VVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDA  103
            VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A R NR  +A
Sbjct  58   VVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRRQNA  117

Query  104  AIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQAR  163
            A + A A +   R+       + RR + L +   VS +  E   A+A  ++A+ A   A 
Sbjct  118  ATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQAQAAVKAAL  175

Query  164  IGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYV  219
              E +AR    G+ +LR    ++ A   L  A L LQ + +RA   G ++   +  G  V
Sbjct  176  AEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQV  235

Query  220  PAGTPVAALVD-DRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFGARVAAIDAGVK  277
             AG P+ A+V    + + A+F+E  LR+++ G  A +V D    + V+  RVA   AG  
Sbjct  236  AAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTG  295

Query  278  EGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
                 A   + A   +  W++  QR  + +VL+
Sbjct  296  S----AFSLIPAQNATGNWIKVVQRVPVRIVLN  324


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 67.4 bits (163),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 137/284 (48%), Gaps = 16/284 (6%)

Query  35   TPQAQLTRPVVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEA  94
            T  A +   VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  95   ERTNRELDAAIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAAR  154
             R NR  +AA + A A +   R+       + RR + L +   VS +  E   A+A  ++
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  172

Query  155  ARVAAAQARIGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSN  210
            A+ A   A   E +AR    G+ +LR    ++ A   L  A L LQ + +RA   G ++ 
Sbjct  173  AQAAVKAALAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  232

Query  211  LQLTPGTYVPAGTPVAALV---DDRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFG  266
              +  G  V AG P+ A+V   D  +D  A+F+E  LR+++ G  A +V D    + V+ 
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDMWVD--ANFKETQLRHMKIGQPAELVSDLYGKQIVYR  290

Query  267  ARVAAIDAGVKEGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
             RVA   AG       A   + A   +  W++  QR  + +VL+
Sbjct  291  GRVAGFSAGTGS----AFSLIPAQNATGNWIKVVQRVPVRIVLN  330


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 67.4 bits (163),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 137/284 (48%), Gaps = 16/284 (6%)

Query  35   TPQAQLTRPVVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEA  94
            T  A +   VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  95   ERTNRELDAAIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAAR  154
             R NR  +AA + A A +   R+       + RR + L +   VS +  E   A+A  ++
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  172

Query  155  ARVAAAQARIGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSN  210
            A+ A   A   E +AR    G+ +LR    ++ A   L  A L LQ + +RA   G ++ 
Sbjct  173  AQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  232

Query  211  LQLTPGTYVPAGTPVAALV---DDRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFG  266
              +  G  V AG P+ A+V   D  +D  A+F+E  LR+++ G  A +V D    + V+ 
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDVWVD--ANFKETQLRHMKIGQPAELVSDLYGKQIVYR  290

Query  267  ARVAAIDAGVKEGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
             RVA   AG       A   + A   +  W++  QR  + +VL+
Sbjct  291  GRVAGFSAGTGS----AFSLIPAQNATGNWIKVVQRVPVRIVLN  330


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 67.4 bits (163),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 133/273 (49%), Gaps = 12/273 (4%)

Query  44   VVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDA  103
            VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A R NR  +A
Sbjct  64   VVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRRQNA  123

Query  104  AIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQAR  163
            A + A A +   R+       + RR + L +   VS +  E   A+A  ++A+ A   A 
Sbjct  124  ATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQAQAAVKAAL  181

Query  164  IGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYV  219
              E +AR    G+ +LR    ++ A   L  A L LQ + +RA   G ++   +  G  V
Sbjct  182  AEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQV  241

Query  220  PAGTPVAALVD-DRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFGARVAAIDAGVK  277
             AG P+ A+V    + + A+F+E  LR+++ G  A +V D    + V+  RVA   AG  
Sbjct  242  AAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTG  301

Query  278  EGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
                 A   + A   +  W++  QR  + +VL+
Sbjct  302  S----AFSLIPAQNATGNWIKVVQRVPVRIVLN  330


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 67.0 bits (162),  Expect = 3e-12, Method: Compositional matrix adjust.
 Identities = 82/276 (30%), Positives = 135/276 (49%), Gaps = 18/276 (7%)

Query  44   VVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDA  103
            VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A R NR+ +A
Sbjct  64   VVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRQQNA  123

Query  104  AIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQAR  163
            A + A A +   R+       + RR + L +   VS +  E   A+A  ++A+ A   A 
Sbjct  124  ATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQAQAAVKAAL  181

Query  164  IGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYV  219
              E +AR    G+  LR    ++ A   L  A L LQ + +RA   G ++   +  G  V
Sbjct  182  AEESSARAALGGQVALREQPAVQTAIGRLKDAWLNLQRTQIRAPTDGQVAKRSVQVGQQV  241

Query  220  PAGTPVAALV---DDRIDIVADFREKSLRYVRPGDRAAVVFDARPGEVFGARVA--AIDA  274
             AG P+ A+V   D  +D  A+F+E  LR+++ G  A +V D     ++G ++    + A
Sbjct  242  AAGAPLMAVVPLSDVWVD--ANFKETQLRHMKIGQPAELVSD-----LYGKQIVYRGMVA  294

Query  275  GVKEGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
            G   G   A   + A   +  W++  QR  + +VL+
Sbjct  295  GFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLN  330


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 66.2 bits (160),  Expect = 6e-12, Method: Compositional matrix adjust.
 Identities = 81/273 (30%), Positives = 132/273 (48%), Gaps = 12/273 (4%)

Query  44   VVRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDA  103
            VV+V P+  G V +VL  +   V+ G+VL  LD +   LA  +A+  L +A R NR  +A
Sbjct  58   VVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRRQNA  117

Query  104  AIASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQAR  163
            A + A A +   R+       + RR + L +   VS +  E   A+A  ++A+ A   A 
Sbjct  118  ATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQAQAAVKAAL  175

Query  164  IGELTARRGTAGEDNLR----LRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYV  219
              E +AR    G+ +LR    ++ A   L  A L LQ + +R    G ++   +  G  V
Sbjct  176  AEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRTPADGQVAKRSVQVGQQV  235

Query  220  PAGTPVAALVD-DRIDIVADFREKSLRYVRPGDRAAVVFDARPGE-VFGARVAAIDAGVK  277
             AG P+ A+V    + + A+F+E  LR+++ G  A +V D    + V+  RVA   AG  
Sbjct  236  AAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTG  295

Query  278  EGQLDANGDLAAPVTSDRWVRDAQRQRLHVVLD  310
                 A   + A   +  W++  QR  + +VL+
Sbjct  296  S----AFSLIPAQNATGNWIKVVQRVPVRIVLN  324


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 53.5 bits (127),  Expect = 7e-08, Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 77/179 (43%), Gaps = 45/179 (25%)

Query  45   VRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDAA  104
            V + P+VSG++  V   +   V+ G++LF +DP PF     +AEL        NR     
Sbjct  72   VDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDPRPF-----EAEL--------NR-----  113

Query  105  IASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQARI  164
               AKA L +A +      S   R  +L+Q + VS+Q                       
Sbjct  114  ---AKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQ-----------------------  147

Query  165  GELTARRGTAGEDNLRLRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYVPAGT  223
             EL      A   N  L+ AR A+  ARL L+Y+ + A  +G +S  ++T G  V AG 
Sbjct  148  -ELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  205


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 53.5 bits (127),  Expect = 9e-08, Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 77/179 (43%), Gaps = 45/179 (25%)

Query  45   VRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDAA  104
            V + P+VSG++  V   +   V+ G++LF +DP PF     +AEL        NR     
Sbjct  72   VDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPF-----EAEL--------NR-----  113

Query  105  IASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQARI  164
               AKA L +A +      S   R  +L+Q + VS+Q                       
Sbjct  114  ---AKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQ-----------------------  147

Query  165  GELTARRGTAGEDNLRLRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYVPAGT  223
             EL      A   N  L+ AR A+  ARL L+Y+ + A  +G +S  ++T G  V AG 
Sbjct  148  -ELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  205


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 53.5 bits (127),  Expect = 9e-08, Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 77/179 (43%), Gaps = 45/179 (25%)

Query  45   VRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDAA  104
            V + P+VSG++  V   +   V+ G++LF +DP PF     +AEL        NR     
Sbjct  72   VDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPF-----EAEL--------NR-----  113

Query  105  IASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQARI  164
               AKA L +A +      S   R  +L+Q + VS+Q                       
Sbjct  114  ---AKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQ-----------------------  147

Query  165  GELTARRGTAGEDNLRLRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYVPAGT  223
             EL      A   N  L+ AR A+  ARL L+Y+ + A  +G +S  ++T G  V AG 
Sbjct  148  -ELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  205


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 53.5 bits (127),  Expect = 9e-08, Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 77/179 (43%), Gaps = 45/179 (25%)

Query  45   VRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDAA  104
            V + P+VSG++  V   +   V+ G++LF +DP PF     +AEL        NR     
Sbjct  72   VDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPF-----EAEL--------NR-----  113

Query  105  IASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQARI  164
               AKA L +A +      S   R  +L+Q + VS+Q                       
Sbjct  114  ---AKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQ-----------------------  147

Query  165  GELTARRGTAGEDNLRLRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYVPAGT  223
             EL      A   N  L+ AR A+  ARL L+Y+ + A  +G +S  ++T G  V AG 
Sbjct  148  -ELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  205


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 53.1 bits (126),  Expect = 1e-07, Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 77/179 (43%), Gaps = 45/179 (25%)

Query  45   VRVAPRVSGQVAEVLVSNNGHVQPGEVLFRLDPEPFRLAVRQAELALEEAERTNRELDAA  104
            V + P+VSG++  V   +   V+ G++LF +DP PF     +AEL        NR     
Sbjct  48   VDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPF-----EAEL--------NR-----  89

Query  105  IASAKADLLAARSSAGELDSEARRTAQLVQRHHVSQQMHEQVSAQAQAARARVAAAQARI  164
               AKA L +A +      S   R  +L+Q + VS+Q                       
Sbjct  90   ---AKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQ-----------------------  123

Query  165  GELTARRGTAGEDNLRLRQARNALAQARLQLQYSSVRADRAGTLSNLQLTPGTYVPAGT  223
             EL      A   N  L+ AR A+  ARL L+Y+ + A  +G +S  ++T G  V AG 
Sbjct  124  -ELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGN  181



Lambda      K        H        a         alpha
   0.320    0.133    0.376    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2628522451


Query= g3968.t1

Length=302
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  84.7    2e-18
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  84.3    3e-18
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  84.3    3e-18
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  84.3    3e-18
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  84.0    3e-18
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  74.7    5e-15
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  74.7    5e-15
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  74.3    6e-15
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  74.3    6e-15
VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  74.3    7e-15
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  73.9    1e-14
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  73.6    1e-14
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  73.6    1e-14
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  73.6    1e-14
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  73.2    2e-14
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  73.2    2e-14
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  71.6    5e-14
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  65.5    5e-12
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  55.5    1e-08
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  55.5    1e-08
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  55.1    2e-08
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  54.7    2e-08
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  54.3    3e-08
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  54.3    3e-08
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  54.3    4e-08
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  54.3    4e-08
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  54.3    4e-08
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  53.9    4e-08
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  53.5    6e-08
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  53.5    6e-08
VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC [M...  52.8    1e-07


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 84.7 bits (208),  Expect = 2e-18, Method: Compositional matrix adjust.
 Identities = 86/271 (32%), Positives = 127/271 (47%), Gaps = 44/271 (16%)

Query  18   VAVFIGRTL--WVNYMDTPWTRDGRVRA-DVINVAADVSGIVVDVPVRDNQLVKKGDLLM  74
            VA  + +T+  W  Y        GR+ A D +++   VSG +V V  +D  LVKKGDLL 
Sbjct  48   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLVAVHFKDGSLVKKGDLLF  100

Query  75   QIDPDHYRIAVKQAESLVASRKATLEMRQLN-ARRRAEMDEMVVSRESRDDAHNTAAAAM  133
             IDP  +   + +A++ +AS +A +     N +R +  +    VSR+  D A N A +A 
Sbjct  101  TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  160

Query  134  ADYEQAKAQLDAARLNLERTRVVAQVDGYVTNLNVHRGDYARVGEAKMAVIDKNSYW-VY  192
            A+ + A+A + +ARLNLE TR+ A V G ++   V  G+    G     +    S   +Y
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  220

Query  193  GYF---EETKLPYIREGD-----PVDMQLM--SGEHLKGHVESIARGIYDRDNPESRELT  242
              F   E+T L YI         PV M L   +G   +G + SI       DN       
Sbjct  221  ASFDVDEQTYLKYISNQRNSSQVPVYMGLANETGFTREGTINSI-------DN-------  266

Query  243  ADVNPTFNWVRLAQRVPVRVHIDEVPDGVLL  273
             ++N T   +R      VR   D  P+GVLL
Sbjct  267  -NLNTTSGTIR------VRATFDN-PNGVLL  289


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 84.3 bits (207),  Expect = 3e-18, Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 127/271 (47%), Gaps = 44/271 (16%)

Query  18   VAVFIGRTL--WVNYMDTPWTRDGRVRA-DVINVAADVSGIVVDVPVRDNQLVKKGDLLM  74
            VA  + +T+  W  Y        GR+ A D +++   VSG ++ V  +D  LVKKGDLL 
Sbjct  48   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLF  100

Query  75   QIDPDHYRIAVKQAESLVASRKATLEMRQLN-ARRRAEMDEMVVSRESRDDAHNTAAAAM  133
             IDP  +   + +A++ +AS +A +     N +R +  +    VSR+  D A N A +A 
Sbjct  101  TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  160

Query  134  ADYEQAKAQLDAARLNLERTRVVAQVDGYVTNLNVHRGDYARVGEAKMAVIDKNSYW-VY  192
            A+ + A+A + +ARLNLE TR+ A V G ++   V  G+    G     +    S   +Y
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  220

Query  193  GYF---EETKLPYIREGD-----PVDMQLM--SGEHLKGHVESIARGIYDRDNPESRELT  242
              F   E+T L YI         PV M L   +G   +G + SI       DN       
Sbjct  221  ASFDVDEQTYLKYISNQRNSAQVPVYMGLANETGFTREGTINSI-------DN-------  266

Query  243  ADVNPTFNWVRLAQRVPVRVHIDEVPDGVLL  273
             ++N T   +R      VR   D  P+GVLL
Sbjct  267  -NLNTTSGTIR------VRATFDN-PNGVLL  289


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 84.3 bits (207),  Expect = 3e-18, Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 127/271 (47%), Gaps = 44/271 (16%)

Query  18   VAVFIGRTL--WVNYMDTPWTRDGRVRA-DVINVAADVSGIVVDVPVRDNQLVKKGDLLM  74
            VA  + +T+  W  Y        GR+ A D +++   VSG ++ V  +D  LVKKGDLL 
Sbjct  48   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLF  100

Query  75   QIDPDHYRIAVKQAESLVASRKATLEMRQLN-ARRRAEMDEMVVSRESRDDAHNTAAAAM  133
             IDP  +   + +A++ +AS +A +     N +R +  +    VSR+  D A N A +A 
Sbjct  101  TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  160

Query  134  ADYEQAKAQLDAARLNLERTRVVAQVDGYVTNLNVHRGDYARVGEAKMAVIDKNSYW-VY  192
            A+ + A+A + +ARLNLE TR+ A V G ++   V  G+    G     +    S   +Y
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  220

Query  193  GYF---EETKLPYIREGD-----PVDMQLM--SGEHLKGHVESIARGIYDRDNPESRELT  242
              F   E+T L YI         PV M L   +G   +G + SI       DN       
Sbjct  221  ASFDVDEQTYLKYISNQRNSSQVPVYMGLANETGFTREGTINSI-------DN-------  266

Query  243  ADVNPTFNWVRLAQRVPVRVHIDEVPDGVLL  273
             ++N T   +R      VR   D  P+GVLL
Sbjct  267  -NLNTTSGTIR------VRATFDN-PNGVLL  289


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 84.3 bits (207),  Expect = 3e-18, Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 127/271 (47%), Gaps = 44/271 (16%)

Query  18   VAVFIGRTL--WVNYMDTPWTRDGRVRA-DVINVAADVSGIVVDVPVRDNQLVKKGDLLM  74
            VA  + +T+  W  Y        GR+ A D +++   VSG ++ V  +D  LVKKGDLL 
Sbjct  48   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLF  100

Query  75   QIDPDHYRIAVKQAESLVASRKATLEMRQLN-ARRRAEMDEMVVSRESRDDAHNTAAAAM  133
             IDP  +   + +A++ +AS +A +     N +R +  +    VSR+  D A N A +A 
Sbjct  101  TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  160

Query  134  ADYEQAKAQLDAARLNLERTRVVAQVDGYVTNLNVHRGDYARVGEAKMAVIDKNSYW-VY  192
            A+ + A+A + +ARLNLE TR+ A V G ++   V  G+    G     +    S   +Y
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  220

Query  193  GYF---EETKLPYIREGD-----PVDMQLM--SGEHLKGHVESIARGIYDRDNPESRELT  242
              F   E+T L YI         PV M L   +G   +G + SI       DN       
Sbjct  221  ASFDVDEQTYLKYISNQRNSSQVPVYMGLANETGFTREGTINSI-------DN-------  266

Query  243  ADVNPTFNWVRLAQRVPVRVHIDEVPDGVLL  273
             ++N T   +R      VR   D  P+GVLL
Sbjct  267  -NLNTTSGTIR------VRATFDN-PNGVLL  289


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 84.0 bits (206),  Expect = 3e-18, Method: Compositional matrix adjust.
 Identities = 84/271 (31%), Positives = 126/271 (46%), Gaps = 44/271 (16%)

Query  18   VAVFIGRTL--WVNYMDTPWTRDGRVRA-DVINVAADVSGIVVDVPVRDNQLVKKGDLLM  74
            VA  + +T+  W  Y        GR+ A D +++   VSG ++ V  +D  LVKKGDLL 
Sbjct  24   VAPVVSKTITDWQEY-------SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLF  76

Query  75   QIDPDHYRIAVKQAESLVASRKATLEMRQLN-ARRRAEMDEMVVSRESRDDAHNTAAAAM  133
             IDP  +   + +A++ +AS +A +     N +R +  +    VSR+  D A N A +A 
Sbjct  77   TIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSAN  136

Query  134  ADYEQAKAQLDAARLNLERTRVVAQVDGYVTNLNVHRGDYARVGEAKMAVIDKNS----Y  189
            A+ + A+A + +ARLNLE TR+ A V G ++   V  G+    G     +    S    Y
Sbjct  137  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLY  196

Query  190  WVYGYFEETKLPYIREGD-----PVDMQLM--SGEHLKGHVESIARGIYDRDNPESRELT  242
              +   E+T L YI         PV M L   +G   +G + SI       DN       
Sbjct  197  ASFDVDEQTYLKYISNQRNSAQVPVYMGLANETGFTREGTINSI-------DN-------  242

Query  243  ADVNPTFNWVRLAQRVPVRVHIDEVPDGVLL  273
             ++N T   +R      VR   D  P+GVLL
Sbjct  243  -NLNTTSGTIR------VRATFDN-PNGVLL  265


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 74.7 bits (182),  Expect = 5e-15, Method: Compositional matrix adjust.
 Identities = 91/317 (29%), Positives = 134/317 (42%), Gaps = 68/317 (21%)

Query  36   TRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH---------------  80
            T D  V   V+ V     G V  V   D   VKKGD+L  +D D+               
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  81   ------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRDDAH-------  126
                     A  QA + VA R+A L   Q + RRR+ + E   VS E  + AH       
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  172

Query  127  ------------NTAAAAMA---------DYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
                        ++A AA+          + + A  +L  A LNL+RT++ A  DG V  
Sbjct  173  AQAAVKAALAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  232

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLMSGEHL--KGH  222
             +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   + G+ +  +G 
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  292

Query  223  VESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGVLLSAGITCTV  281
            V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D   L  G++ TV
Sbjct  293  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  347

Query  282  IVKPQGRDDQASAAQAP  298
             V         SAA AP
Sbjct  348  KVD-------TSAAGAP  357


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 74.7 bits (182),  Expect = 5e-15, Method: Compositional matrix adjust.
 Identities = 93/327 (28%), Positives = 137/327 (42%), Gaps = 70/327 (21%)

Query  26   LWVNYMDTPWTRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH-----  80
            LW  + +   T D  V   V+ V     G V  V   D   VKKGD+L  +D D+     
Sbjct  47   LWWQHEEE--TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  104

Query  81   ----------------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRD  123
                               A  QA + VA R+A L   Q + RRR+ + E   VS E  +
Sbjct  105  ERAKNELIQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAE--E  162

Query  124  DAH-------------------NTAAAAMADY---------EQAKAQLDAARLNLERTRV  155
             AH                   ++A AA+            + A  +L  A LNL+RT++
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQI  222

Query  156  VAQVDGYVTNLNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLM  214
             A  DG V   +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   +
Sbjct  223  RAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDL  282

Query  215  SGEHL--KGHVESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGV  271
             G+ +  +G V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D  
Sbjct  283  YGKQIVYRGRVAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRH  337

Query  272  LLSAGITCTVIVKPQGRDDQASAAQAP  298
             L  G++ TV V         SAA AP
Sbjct  338  PLRIGLSMTVKVD-------TSAAGAP  357


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 74.3 bits (181),  Expect = 6e-15, Method: Compositional matrix adjust.
 Identities = 96/327 (29%), Positives = 138/327 (42%), Gaps = 70/327 (21%)

Query  26   LWVNYMDTPWTRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH-----  80
            LW  + +   T D  V   V+ V     G V  V   D   VKKGD+L  +D D+     
Sbjct  47   LWWQHEEE--TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  104

Query  81   ----------------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRD  123
                               A  QA + VA R+A L   Q + RRR+ + E   VS E  +
Sbjct  105  ERAKNELIQAVRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--E  162

Query  124  DAH-------------------NTAAAAM----ADYEQAKAQ-----LDAARLNLERTRV  155
             AH                   ++A AA+    A  EQ   Q     L  A LNL+RT++
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVALREQPAVQTAIGRLKDAWLNLQRTQI  222

Query  156  VAQVDGYVTNLNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLM  214
             A  DG V   +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   +
Sbjct  223  RAPTDGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDL  282

Query  215  SGEHL--KGHVESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGV  271
             G+ +  +G V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D  
Sbjct  283  YGKQIVYRGMVAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRH  337

Query  272  LLSAGITCTVIVKPQGRDDQASAAQAP  298
             L  G++ TV V         SAA AP
Sbjct  338  PLRIGLSMTVKVD-------TSAASAP  357


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 74.3 bits (181),  Expect = 6e-15, Method: Compositional matrix adjust.
 Identities = 93/327 (28%), Positives = 137/327 (42%), Gaps = 70/327 (21%)

Query  26   LWVNYMDTPWTRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH-----  80
            LW  + +   T D  V   V+ V     G V  V   D   VKKGD+L  +D D+     
Sbjct  41   LWWQHEEE--TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  98

Query  81   ----------------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRD  123
                               A  QA + VA R+A L   Q + RRR+ + E   VS E  +
Sbjct  99   ERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--E  156

Query  124  DAH-------------------NTAAAAMADY---------EQAKAQLDAARLNLERTRV  155
             AH                   ++A AA+            + A  +L  A LNL+RT++
Sbjct  157  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQI  216

Query  156  VAQVDGYVTNLNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLM  214
             A  DG V   +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   +
Sbjct  217  RAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDL  276

Query  215  SGEHL--KGHVESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGV  271
             G+ +  +G V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D  
Sbjct  277  YGKQIVYRGRVAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRH  331

Query  272  LLSAGITCTVIVKPQGRDDQASAAQAP  298
             L  G++ TV V         SAA AP
Sbjct  332  PLRIGLSMTVKVD-------TSAAGAP  351


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 74.3 bits (181),  Expect = 7e-15, Method: Compositional matrix adjust.
 Identities = 91/315 (29%), Positives = 131/315 (42%), Gaps = 64/315 (20%)

Query  36   TRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH---------------  80
            T D  V   V+ V     G V  V   D   VKKGD+L  +D D+               
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  81   ------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRDDA--------  125
                     A  QA + VA R+A L   Q + RRR+ + E   VS E    A        
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARTAVSQAQ  168

Query  126  ---------HNTAAAAMA---------DYEQAKAQLDAARLNLERTRVVAQVDGYVTNLN  167
                      ++A AA+          + + A  +L  A LNL RT+V A  DG V   +
Sbjct  169  AAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQVAKRS  228

Query  168  VHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLMSGEHL--KGHVE  224
            V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   + G+ +  +G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVA  288

Query  225  SIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGVLLSAGITCTVIV  283
              + G        +  L    N T NW+++ QRVPVR+ ++ E  D   L  G++ TV V
Sbjct  289  GFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKV  343

Query  284  KPQGRDDQASAAQAP  298
                     SAA AP
Sbjct  344  D-------TSAAGAP  351


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 73.9 bits (180),  Expect = 1e-14, Method: Compositional matrix adjust.
 Identities = 91/317 (29%), Positives = 133/317 (42%), Gaps = 68/317 (21%)

Query  36   TRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH---------------  80
            T D  V   V+ V     G V  V   D   VKKGD+L  +D D+               
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  81   ------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRDDAH-------  126
                     A  QA + VA R+A L   Q + RRR+ + E   VS E  + AH       
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  172

Query  127  ------------NTAAAAMADY---------EQAKAQLDAARLNLERTRVVAQVDGYVTN  165
                        ++A AA+            + A  +L  A LNL+RT++ A  DG V  
Sbjct  173  AQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRASADGQVAK  232

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLMSGEHL--KGH  222
             +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   + G+ +  +G 
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  292

Query  223  VESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGVLLSAGITCTV  281
            V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D   L  G++ TV
Sbjct  293  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  347

Query  282  IVKPQGRDDQASAAQAP  298
             V         SAA AP
Sbjct  348  KVD-------TSAAGAP  357


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 73.6 bits (179),  Expect = 1e-14, Method: Compositional matrix adjust.
 Identities = 91/317 (29%), Positives = 133/317 (42%), Gaps = 68/317 (21%)

Query  36   TRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH---------------  80
            T D  V   V+ V     G V  V   D   VKKGD+L  +D D+               
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  81   ------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRDDAH-------  126
                     A  QA + VA R+A L   Q + RRR+ + E   VS E  + AH       
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  166

Query  127  ------------NTAAAAMADY---------EQAKAQLDAARLNLERTRVVAQVDGYVTN  165
                        ++A AA+            + A  +L  A LNL+RT++ A  DG V  
Sbjct  167  AQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLMSGEHL--KGH  222
             +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   + G+ +  +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  223  VESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGVLLSAGITCTV  281
            V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D   L  G++ TV
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  282  IVKPQGRDDQASAAQAP  298
             V         SAA AP
Sbjct  342  KVD-------TSAAGAP  351


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 73.6 bits (179),  Expect = 1e-14, Method: Compositional matrix adjust.
 Identities = 91/317 (29%), Positives = 133/317 (42%), Gaps = 68/317 (21%)

Query  36   TRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH---------------  80
            T D  V   V+ V     G V  V   D   VKKGD+L  +D D+               
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  81   ------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRDDAH-------  126
                     A  QA + VA R+A L   Q + RRR+ + E   VS E  + AH       
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  166

Query  127  ------------NTAAAAMADY---------EQAKAQLDAARLNLERTRVVAQVDGYVTN  165
                        ++A AA+            + A  +L  A LNL+RT++ A  DG V  
Sbjct  167  AQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLMSGEHL--KGH  222
             +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   + G+ +  +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  223  VESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGVLLSAGITCTV  281
            V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D   L  G++ TV
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  282  IVKPQGRDDQASAAQAP  298
             V         SAA AP
Sbjct  342  KVD-------TSAAGAP  351


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 73.6 bits (179),  Expect = 1e-14, Method: Compositional matrix adjust.
 Identities = 91/317 (29%), Positives = 133/317 (42%), Gaps = 68/317 (21%)

Query  36   TRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH---------------  80
            T D  V   V+ V     G V  V   D   VKKGD+L  +D D+               
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  81   ------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRDDAH-------  126
                     A  QA + VA R+A L   Q + RRR+ + E   VS E  + AH       
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  166

Query  127  ------------NTAAAAMADY---------EQAKAQLDAARLNLERTRVVAQVDGYVTN  165
                        ++A AA+            + A  +L  A LNL+RT++ A  DG V  
Sbjct  167  AQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLMSGEHL--KGH  222
             +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   + G+ +  +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  223  VESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGVLLSAGITCTV  281
            V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D   L  G++ TV
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  282  IVKPQGRDDQASAAQAP  298
             V         SAA AP
Sbjct  342  KVD-------TSAAGAP  351


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 73.2 bits (178),  Expect = 2e-14, Method: Compositional matrix adjust.
 Identities = 91/317 (29%), Positives = 133/317 (42%), Gaps = 68/317 (21%)

Query  36   TRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH---------------  80
            T D  V   V+ V     G V  V   D   VKKGD+L  +D D+               
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  81   ------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRDDAH-------  126
                     A  QA + VA R+A L   Q + RRR+ + E   VS E  + AH       
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  172

Query  127  ------------NTAAAAMADY---------EQAKAQLDAARLNLERTRVVAQVDGYVTN  165
                        ++A AA+            + A  +L  A LNL+RT++ A  DG V  
Sbjct  173  AQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  232

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLMSGEHL--KGH  222
             +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   + G+ +  +G 
Sbjct  233  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  292

Query  223  VESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGVLLSAGITCTV  281
            V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D   L  G++ TV
Sbjct  293  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  347

Query  282  IVKPQGRDDQASAAQAP  298
             V         SAA AP
Sbjct  348  KVD-------TSAAGAP  357


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 73.2 bits (178),  Expect = 2e-14, Method: Compositional matrix adjust.
 Identities = 91/317 (29%), Positives = 133/317 (42%), Gaps = 68/317 (21%)

Query  36   TRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH---------------  80
            T D  V   V+ V     G V  V   D   VKKGD+L  +D D+               
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  81   ------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRDDAH-------  126
                     A  QA + VA R+A L   Q + RRR+ + E   VS E  + AH       
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  166

Query  127  ------------NTAAAAMADY---------EQAKAQLDAARLNLERTRVVAQVDGYVTN  165
                        ++A AA+            + A  +L  A LNL+RT++ A  DG V  
Sbjct  167  AQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAK  226

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLMSGEHL--KGH  222
             +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   + G+ +  +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  223  VESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGVLLSAGITCTV  281
            V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D   L  G++ TV
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  282  IVKPQGRDDQASAAQAP  298
             V         SAA AP
Sbjct  342  KVD-------TSAAGAP  351


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 71.6 bits (174),  Expect = 5e-14, Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 132/317 (42%), Gaps = 68/317 (21%)

Query  36   TRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDH---------------  80
            T D  V   V+ V     G V  V   D   VKKGD+L  +D D+               
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  81   ------YRIAVKQAESLVASRKATLEMRQLNARRRAEMDEM-VVSRESRDDAH-------  126
                     A  QA + VA R+A L   Q + RRR+ + E   VS E  + AH       
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAE--ELAHARAAVSQ  166

Query  127  ------------NTAAAAMADY---------EQAKAQLDAARLNLERTRVVAQVDGYVTN  165
                        ++A AA+            + A  +L  A LNL+RT++    DG V  
Sbjct  167  AQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRTPADGQVAK  226

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVDM-QLMSGEHL--KGH  222
             +V  G     G   MAV+  +  WV   F+ET+L +++ G P ++   + G+ +  +G 
Sbjct  227  RSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGR  286

Query  223  VESIARGIYDRDNPESRELTADVNPTFNWVRLAQRVPVRVHID-EVPDGVLLSAGITCTV  281
            V   + G        +  L    N T NW+++ QRVPVR+ ++ E  D   L  G++ TV
Sbjct  287  VAGFSAG-----TGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTV  341

Query  282  IVKPQGRDDQASAAQAP  298
             V         SAA AP
Sbjct  342  KVD-------TSAAGAP  351


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 65.5 bits (158),  Expect = 5e-12, Method: Compositional matrix adjust.
 Identities = 77/323 (24%), Positives = 139/323 (43%), Gaps = 59/323 (18%)

Query  14   LILLVAVFIGRTLWVNYMDTPWTRDGRVRADVINVAADVSGIVVDVPVRDNQLVKKGDLL  73
            +I+L+ VF+   ++      P+T +  V A+V  VAA+V G + ++ V++ Q VKKG  L
Sbjct  11   VIILLCVFLFILIYHYSYLFPFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKKGQPL  70

Query  74   MQIDPDHYRIAVKQAESLVASRKATLEM--RQLNARRRAEMDEMVVSRESRDD-AHNTAA  130
              +    Y +A ++A S V   KA L +  +Q+   +     +  +  + R D  HN +A
Sbjct  71   FTVFKAPYELAYRKAVSHVQEAKAQLLLFNKQVEKTKYLLQAQKELYEKFRFDYEHNYSA  130

Query  131  -------------------AAMADYEQAKAQLDA---------------------ARLNL  150
                               AA++  +  + +L+                      A+++L
Sbjct  131  SRDHAVSKLTVNTMLKEKNAALSKLKALEKELEVNQQQVIVQKKKIDSLIAVMKNAKIDL  190

Query  151  ERTRVVAQVDGYVTNLNVHRGDYARVGEAKMAVIDKNSYWVYGYFEETKLPYIREGDPVD  210
            + T V A+ +G V ++ V  G   +  +   A+ D ++ ++   F ET L  ++ GD V 
Sbjct  191  DETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQANFNETDLRRVQPGDKVS  250

Query  211  M--QLMSGEHLKGHVESIARGIYDRDNPESR-------ELTADVNPTFNWVRLAQRVPVR  261
            +  ++  G  +   V      I  R+   SR       ++    N   NW  L QR+PV+
Sbjct  251  IFPRMYFGSKIYHGV------ILSRNWAASRLETHRATQIQIVRNSESNWFLLPQRLPVQ  304

Query  262  VHI-DEVPDGVLLSAGITCTVIV  283
            + I D  P    LS G +  V +
Sbjct  305  IQITDYDPVHYPLSIGASAYVYI  327


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 55.5 bits (132),  Expect = 1e-08, Method: Compositional matrix adjust.
 Identities = 38/133 (29%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 55.5 bits (132),  Expect = 1e-08, Method: Compositional matrix adjust.
 Identities = 38/133 (29%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 55.1 bits (131),  Expect = 2e-08, Method: Compositional matrix adjust.
 Identities = 38/133 (29%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 54.7 bits (130),  Expect = 2e-08, Method: Compositional matrix adjust.
 Identities = 39/147 (27%), Positives = 71/147 (48%), Gaps = 1/147 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A ++L R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVY  192
              V  G     G+A +    + +  +Y
Sbjct  194  SKVSEGTLLNAGDATVLATIRQTNPMY  220


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 54.3 bits (129),  Expect = 3e-08, Method: Compositional matrix adjust.
 Identities = 38/133 (29%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 54.3 bits (129),  Expect = 3e-08, Method: Compositional matrix adjust.
 Identities = 38/133 (29%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 54.3 bits (129),  Expect = 4e-08, Method: Compositional matrix adjust.
 Identities = 38/133 (29%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 54.3 bits (129),  Expect = 4e-08, Method: Compositional matrix adjust.
 Identities = 38/133 (29%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 54.3 bits (129),  Expect = 4e-08, Method: Compositional matrix adjust.
 Identities = 38/133 (29%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 53.9 bits (128),  Expect = 4e-08, Method: Compositional matrix adjust.
 Identities = 38/133 (29%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    VSR+  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 53.5 bits (127),  Expect = 6e-08, Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    +S++  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVSADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 53.5 bits (127),  Expect = 6e-08, Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (49%), Gaps = 1/133 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y   ++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    +S++  D A     +A A  + A+A + +A +NL R+R+ A + G++  
Sbjct  134  ARYKPLVSADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGE  178
              V  G     G+
Sbjct  194  SKVSEGTLLNAGD  206


>VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240355]
Length=412

 Score = 52.8 bits (125),  Expect = 1e-07, Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 72/147 (49%), Gaps = 1/147 (1%)

Query  47   NVAADVSGIVVDVPVRDNQLVKKGDLLMQIDPDHYRIAVKQAESLVASRKATLEMRQLN-  105
            +V A V GI+     ++   V+ G  L QID   Y  +++ A + +A+ +ATL     + 
Sbjct  74   DVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEASLESARAQLATAQATLAKADADL  133

Query  106  ARRRAEMDEMVVSRESRDDAHNTAAAAMADYEQAKAQLDAARLNLERTRVVAQVDGYVTN  165
            AR +  +    +S++  D A     +A A  + A+A + +A ++L R+R+ A + G++  
Sbjct  134  ARYKPLVAADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQ  193

Query  166  LNVHRGDYARVGEAKMAVIDKNSYWVY  192
              V  G     G+A +    + +  +Y
Sbjct  194  SKVSEGTLLNAGDATVLATIRQTNPMY  220



Lambda      K        H        a         alpha
   0.319    0.133    0.383    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2121036966


Query= g1339.t1

Length=257
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  93.2    7e-22
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  91.3    3e-21
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  90.1    9e-21
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  90.1    1e-20
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  90.1    1e-20
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  89.7    1e-20
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  89.7    1e-20
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  89.7    1e-20
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  89.4    2e-20
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  89.4    2e-20
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  89.0    2e-20
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  89.4    2e-20
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  89.0    3e-20
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  89.0    3e-20
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  89.0    3e-20
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  88.2    4e-20
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  86.3    2e-19
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  76.6    3e-16
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  65.9    2e-12
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  65.9    2e-12
VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC [M...  65.1    5e-12
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  63.5    1e-11
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  63.5    2e-11
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  63.5    2e-11
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  63.2    2e-11
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  62.4    4e-11
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  62.4    4e-11
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  62.4    4e-11
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  62.0    5e-11
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  62.0    5e-11
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  62.0    5e-11
VFG049125(gb|WP_004136054) (acrA) acriflavine resistance protein ...  48.5    2e-06
VFG049129(gb|YP_005225489) (acrA) acriflavine resistance protein ...  47.8    3e-06
VFG049128(gb|WP_012542667) (acrA) acriflavine resistance protein ...  47.4    3e-06
VFG049135(gb|WP_008805438) (acrA) acriflavine resistance protein ...  47.4    3e-06
VFG049133(gb|WP_004177236) (acrA) acriflavine resistance protein ...  47.4    3e-06


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 93.2 bits (230),  Expect = 7e-22, Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 120/278 (43%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDLDSANLNVKAM-  102
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L  A   V    
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARTAVSQAQ  168

Query  103  -------------------------QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                                     Q  V  A+  LK A   L +T+V+AP  G V   S
Sbjct  169  AAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQVAKRS  228

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  287

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  288  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  321


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 91.3 bits (225),  Expect = 3e-21, Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 121/278 (44%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++AP  G V   S
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  234

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  293

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  294  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  327


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 90.1 bits (222),  Expect = 9e-21, Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 121/278 (44%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  115  VRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++AP  G V   S
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  234

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  293

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  294  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  327


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 90.1 bits (222),  Expect = 1e-20, Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 121/278 (44%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++AP  G V   S
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  234

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  293

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  294  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  327


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 90.1 bits (222),  Expect = 1e-20, Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 121/278 (44%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++AP  G V   S
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  287

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  288  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  321


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 89.7 bits (221),  Expect = 1e-20, Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 121/278 (44%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++AP  G V   S
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  287

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  288  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  321


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 89.7 bits (221),  Expect = 1e-20, Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 121/278 (44%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++AP  G V   S
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  287

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  288  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  321


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 89.7 bits (221),  Expect = 1e-20, Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 121/278 (44%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++AP  G V   S
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  287

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  288  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  321


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 89.4 bits (220),  Expect = 2e-20, Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 121/278 (44%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  114

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  115  VRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++AP  G V   S
Sbjct  175  AAVKAALAEESSARAALGGQVALREQPAVQTAIGRLKDAWLNLQRTQIRAPTDGQVAKRS  234

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGMV-  293

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  294  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  327


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 89.4 bits (220),  Expect = 2e-20, Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 102/186 (55%), Gaps = 9/186 (5%)

Query  9    GKIRA-EQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELN-AQAQLAKAQ  66
            G++ A +QV + PQVSG +  ++ KD   V  GD+LF ID  PF  AELN A+AQLA A+
Sbjct  40   GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFE-AELNRAKAQLASAE  98

Query  67   SDLA-KANNEADRRRHLSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEV  125
            + +   A+N +  +R +  N +S ++LD A  + ++  AN+  A A ++ A+  L  T +
Sbjct  99   AQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRI  158

Query  126  KAPVSGWVTNLSTRTGDYASTG---KPLFALVDSHSFYV-MGYFEETKLRHI-REGEPAL  180
             APVSG ++      G+  S G   + L +LV     Y      E+T L++I  +   A 
Sbjct  159  TAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQ  218

Query  181  ITLYSG  186
            + +Y G
Sbjct  219  VPVYMG  224


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 89.0 bits (219),  Expect = 2e-20, Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 121/278 (44%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  108

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++AP  G V   S
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRS  228

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  287

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  288  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  321


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 89.4 bits (220),  Expect = 2e-20, Method: Compositional matrix adjust.
 Identities = 61/172 (35%), Positives = 96/172 (56%), Gaps = 8/172 (5%)

Query  9    GKIRA-EQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELN-AQAQLAKAQ  66
            G++ A +QV + PQVSG +  ++ KD   V  GD+LF ID  PF  AELN A+AQLA A+
Sbjct  64   GRLEAIDQVDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDPRPFE-AELNRAKAQLASAE  122

Query  67   SDLA-KANNEADRRRHLSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEV  125
            + +   A+N +  +R +  N +S ++LD A  + ++  AN+  A A ++ A+  L  T +
Sbjct  123  AQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRI  182

Query  126  KAPVSGWVTNLSTRTGDYASTG---KPLFALVDSHSFYV-MGYFEETKLRHI  173
             APVSG ++      G+  S G   + L +LV     Y      E+T L++I
Sbjct  183  TAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYI  234


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 89.0 bits (219),  Expect = 3e-20, Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 102/186 (55%), Gaps = 9/186 (5%)

Query  9    GKIRA-EQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELN-AQAQLAKAQ  66
            G++ A +QV + PQVSG +  ++ KD   V  GD+LF ID  PF  AELN A+AQLA A+
Sbjct  64   GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFE-AELNRAKAQLASAE  122

Query  67   SDLA-KANNEADRRRHLSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEV  125
            + +   A+N +  +R +  N +S ++LD A  + ++  AN+  A A ++ A+  L  T +
Sbjct  123  AQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRI  182

Query  126  KAPVSGWVTNLSTRTGDYASTG---KPLFALVDSHSFYV-MGYFEETKLRHI-REGEPAL  180
             APVSG ++      G+  S G   + L +LV     Y      E+T L++I  +   A 
Sbjct  183  TAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQ  242

Query  181  ITLYSG  186
            + +Y G
Sbjct  243  VPVYMG  248


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 89.0 bits (219),  Expect = 3e-20, Method: Compositional matrix adjust.
 Identities = 61/172 (35%), Positives = 96/172 (56%), Gaps = 8/172 (5%)

Query  9    GKIRA-EQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELN-AQAQLAKAQ  66
            G++ A +QV + PQVSG +  ++ KD   V  GD+LF ID  PF  AELN A+AQLA A+
Sbjct  64   GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFE-AELNRAKAQLASAE  122

Query  67   SDLA-KANNEADRRRHLSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEV  125
            + +   A+N +  +R +  N +S ++LD A  + ++  AN+  A A ++ A+  L  T +
Sbjct  123  AQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRI  182

Query  126  KAPVSGWVTNLSTRTGDYASTG---KPLFALVDSHSFYV-MGYFEETKLRHI  173
             APVSG ++      G+  S G   + L +LV     Y      E+T L++I
Sbjct  183  TAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYI  234


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 89.0 bits (219),  Expect = 3e-20, Method: Compositional matrix adjust.
 Identities = 61/172 (35%), Positives = 96/172 (56%), Gaps = 8/172 (5%)

Query  9    GKIRA-EQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELN-AQAQLAKAQ  66
            G++ A +QV + PQVSG +  ++ KD   V  GD+LF ID  PF  AELN A+AQLA A+
Sbjct  64   GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFE-AELNRAKAQLASAE  122

Query  67   SDLA-KANNEADRRRHLSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEV  125
            + +   A+N +  +R +  N +S ++LD A  + ++  AN+  A A ++ A+  L  T +
Sbjct  123  AQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRI  182

Query  126  KAPVSGWVTNLSTRTGDYASTG---KPLFALVDSHSFYV-MGYFEETKLRHI  173
             APVSG ++      G+  S G   + L +LV     Y      E+T L++I
Sbjct  183  TAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYI  234


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 88.2 bits (217),  Expect = 4e-20, Method: Compositional matrix adjust.
 Identities = 80/278 (29%), Positives = 120/278 (43%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  49   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQA  108

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  109  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  168

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++ P  G V   S
Sbjct  169  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRTPADGQVAKRS  228

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  229  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  287

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  288  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  321


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 86.3 bits (212),  Expect = 2e-19, Method: Compositional matrix adjust.
 Identities = 80/278 (29%), Positives = 120/278 (43%), Gaps = 55/278 (20%)

Query  6    TRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIA------EL---  56
            T D  +    V VTPQ  G++ ++   D   V  GDVL V+D     +A      EL   
Sbjct  55   TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQA  114

Query  57   ------------NAQAQLAKAQSDLAKANNEADRRRHLSRN-YISAEDL-----------  92
                         A AQ+A  ++DLA+A ++  RR  L+ +  +SAE+L           
Sbjct  115  VRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQ  174

Query  93   ----------DSANLNVKAM-----QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLS  137
                       SA   +        Q  V  A+  LK A   L +T+++A   G V   S
Sbjct  175  AAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRASADGQVAKRS  234

Query  138  TRTGDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALIT--LYSGNVKLQGHVG  195
             + G   + G PL A+V     +V   F+ET+LRH++ G+PA +   LY   +  +G V 
Sbjct  235  VQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRV-  293

Query  196  SIGRAIYDQSVESDSGLVPDIKPNVPWVRLAQRVPVRI  233
                A +     S   L+P       W+++ QRVPVRI
Sbjct  294  ----AGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRI  327


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 76.6 bits (187),  Expect = 3e-16, Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 122/299 (41%), Gaps = 50/299 (17%)

Query  4    PWTRDGKIRAEQVSVTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLA  63
            P+T +  + A    V   V G IT + +K+ Q V  G  LF + K P+ +A   A + + 
Sbjct  31   PFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKKGQPLFTVFKAPYELAYRKAVSHVQ  90

Query  64   KAQSDLAKANNEADRRRHL---------------SRNYISAEDLDSANLNVKAM------  102
            +A++ L   N + ++ ++L                 NY ++ D   + L V  M      
Sbjct  91   EAKAQLLLFNKQVEKTKYLLQAQKELYEKFRFDYEHNYSASRDHAVSKLTVNTMLKEKNA  150

Query  103  ----------------------QANVDVALATLKQAQWQLSQTEVKAPVSGWVTNLSTRT  140
                                  +  +D  +A +K A+  L +T V A  +G V ++    
Sbjct  151  ALSKLKALEKELEVNQQQVIVQKKKIDSLIAVMKNAKIDLDETTVYAKQNGAVQDMFVAL  210

Query  141  GDYASTGKPLFALVDSHSFYVMGYFEETKLRHIREGEPALI--TLYSGNVKLQGHVGSIG  198
            G    T KP+FA+ D+ + ++   F ET LR ++ G+   I   +Y G+    G +  + 
Sbjct  211  GTPIKTRKPVFAIADTDTLFIQANFNETDLRRVQPGDKVSIFPRMYFGSKIYHGVI--LS  268

Query  199  RAIYDQSVESDSGLVPDIKPNVP--WVRLAQRVPVRIEF-DALPQDITLVSGTTCSVAI  254
            R      +E+       I  N    W  L QR+PV+I+  D  P    L  G +  V I
Sbjct  269  RNWAASRLETHRATQIQIVRNSESNWFLLPQRLPVQIQITDYDPVHYPLSIGASAYVYI  327


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 65.9 bits (159),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 85/167 (51%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L S + IS ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVSADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 65.9 bits (159),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 85/167 (51%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L S + IS ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVSADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240355]
Length=412

 Score = 65.1 bits (157),  Expect = 5e-12, Method: Compositional matrix adjust.
 Identities = 51/167 (31%), Positives = 86/167 (51%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +  +  +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEASLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L + + IS ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 63.5 bits (153),  Expect = 1e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 63.5 bits (153),  Expect = 2e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 63.5 bits (153),  Expect = 2e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 63.2 bits (152),  Expect = 2e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 62.4 bits (150),  Expect = 4e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 62.4 bits (150),  Expect = 4e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 62.4 bits (150),  Expect = 4e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 62.0 bits (149),  Expect = 5e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 62.0 bits (149),  Expect = 5e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 62.0 bits (149),  Expect = 5e-11, Method: Compositional matrix adjust.
 Identities = 50/167 (30%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query  18   VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQSDLAKANNEAD  77
            V  QV G I +   ++  +V AG  L+ ID + +     +A+AQLA AQ+ LAKA+ +  
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  78   RRRHL-SRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQTEVKAPVSGWVTNL  136
            R + L +   +S ++ D+A    ++ +A V  A A +K A   L+++ + AP+SG++   
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQS  194

Query  137  STRTGDYASTGKP--LFALVDSHSFYV---MGYFEETKL-RHIREGE  177
                G   + G    L  +  ++  YV       E  KL R I EG+
Sbjct  195  KVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG049125(gb|WP_004136054) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella oxytoca E718]
Length=397

 Score = 48.5 bits (114),  Expect = 2e-06, Method: Compositional matrix adjust.
 Identities = 46/145 (32%), Positives = 73/145 (50%), Gaps = 8/145 (6%)

Query  9    GKIRAEQVS-VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQS  67
            G+  A +V+ V PQVSG I + N  +   + AG  L+ ID   +     +A+  LAKAQ 
Sbjct  58   GRTSAYRVAEVRPQVSGIILKRNFTEGSDIQAGVSLYQIDPATYQATYESAKGDLAKAQ-  116

Query  68   DLAKAN-NEADRRRH---LSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQT  123
              A AN ++   +R+   L   YIS +D D+A    +   A V  A A ++ A+  L+ T
Sbjct  117  --AAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYT  174

Query  124  EVKAPVSGWVTNLSTRTGDYASTGK  148
            +V +P+SG +   +   G     G+
Sbjct  175  KVTSPISGRIGKSAVTEGALVQNGQ  199


>VFG049129(gb|YP_005225489) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae 
HS11286]
Length=397

 Score = 47.8 bits (112),  Expect = 3e-06, Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 8/145 (6%)

Query  9    GKIRAEQVS-VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQS  67
            G+  A +++ V PQVSG I + N  +   + AG  L+ ID   +  +  +A+  LAKAQ 
Sbjct  58   GRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQ-  116

Query  68   DLAKAN-NEADRRRH---LSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQT  123
              A AN ++   +R+   L   YIS +D D+A    +   A V  A A ++ A+  L+ T
Sbjct  117  --AAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYT  174

Query  124  EVKAPVSGWVTNLSTRTGDYASTGK  148
            +V +P+SG +   +   G     G+
Sbjct  175  KVTSPISGRIGKSTVTEGALVQNGQ  199


>VFG049128(gb|WP_012542667) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella pneumoniae 342]
Length=397

 Score = 47.4 bits (111),  Expect = 3e-06, Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 8/145 (6%)

Query  9    GKIRAEQVS-VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQS  67
            G+  A +++ V PQVSG I + N  +   + AG  L+ ID   +  +  +A+  LAKAQ 
Sbjct  58   GRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQ-  116

Query  68   DLAKAN-NEADRRRH---LSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQT  123
              A AN ++   +R+   L   YIS +D D+A    +   A V  A A ++ A+  L+ T
Sbjct  117  --AAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYT  174

Query  124  EVKAPVSGWVTNLSTRTGDYASTGK  148
            +V +P+SG +   +   G     G+
Sbjct  175  KVTSPISGRIGKSAVTEGALVQNGQ  199


>VFG049135(gb|WP_008805438) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella variicola At-22]
Length=397

 Score = 47.4 bits (111),  Expect = 3e-06, Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 8/145 (6%)

Query  9    GKIRAEQVS-VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQS  67
            G+  A +++ V PQVSG I + N  +   + AG  L+ ID   +  +  +A+  LAKAQ 
Sbjct  58   GRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQ-  116

Query  68   DLAKAN-NEADRRRH---LSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQT  123
              A AN ++   +R+   L   YIS +D D+A    +   A V  A A ++ A+  L+ T
Sbjct  117  --AAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYT  174

Query  124  EVKAPVSGWVTNLSTRTGDYASTGK  148
            +V +P+SG +   +   G     G+
Sbjct  175  KVTSPISGRIGKSAVTEGALVQNGQ  199


>VFG049133(gb|WP_004177236) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae 
NTUH-K2044]
Length=397

 Score = 47.4 bits (111),  Expect = 3e-06, Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 8/145 (6%)

Query  9    GKIRAEQVS-VTPQVSGSITQLNIKDNQFVNAGDVLFVIDKTPFHIAELNAQAQLAKAQS  67
            G+  A +++ V PQVSG I + N  +   + AG  L+ ID   +  +  +A+  LAKAQ 
Sbjct  58   GRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQ-  116

Query  68   DLAKAN-NEADRRRH---LSRNYISAEDLDSANLNVKAMQANVDVALATLKQAQWQLSQT  123
              A AN ++   +R+   L   YIS +D D+A    +   A V  A A ++ A+  L+ T
Sbjct  117  --AAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYT  174

Query  124  EVKAPVSGWVTNLSTRTGDYASTGK  148
            +V +P+SG +   +   G     G+
Sbjct  175  KVTSPISGRIGKSAVTEGALVQNGQ  199



Lambda      K        H        a         alpha
   0.315    0.130    0.372    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 1678427373


Query= g3139.t1

Length=310
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  75.9    1e-15
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  70.9    1e-13
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  70.9    1e-13
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  70.9    1e-13
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  70.5    2e-13
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  69.3    3e-13
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  68.6    6e-13
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  68.2    9e-13
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  67.8    1e-12
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  67.8    1e-12
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  67.8    1e-12
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  67.8    1e-12
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  67.8    1e-12
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  67.4    1e-12
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  67.0    2e-12
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  65.9    4e-12
VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  64.7    1e-11
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  63.9    2e-11
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  52.0    2e-07
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  52.0    2e-07
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  51.6    2e-07
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  50.8    5e-07
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  50.8    5e-07
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  50.8    5e-07
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  50.8    5e-07
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  50.4    5e-07
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  50.4    5e-07
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  50.4    6e-07
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  49.7    9e-07
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  49.7    9e-07


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 75.9 bits (185),  Expect = 1e-15, Method: Compositional matrix adjust.
 Identities = 80/323 (25%), Positives = 137/323 (42%), Gaps = 56/323 (17%)

Query  13   ITLVLVILAFIAIFRAWVYYTESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKD  72
            + ++L +  FI I+    Y    P+T +A   A+V  +A +V G IT++ V + Q VKK 
Sbjct  11   VIILLCVFLFILIYH---YSYLFPFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKKG  67

Query  73   QVLFTIDQPRYQKALAEAEADV----------------AYYQVLAQEKRQEAGRRN----  112
            Q LFT+ +  Y+ A  +A + V                  Y + AQ++  E  R +    
Sbjct  68   QPLFTVFKAPYELAYRKAVSHVQEAKAQLLLFNKQVEKTKYLLQAQKELYEKFRFDYEHN  127

Query  113  ----------RLGVQAMSRE---------------EIDQANNVLQTVLHQLAKAQATRDL  147
                      +L V  M +E               E++Q   ++Q    ++    A    
Sbjct  128  YSASRDHAVSKLTVNTMLKEKNAALSKLKALEKELEVNQQQVIVQK--KKIDSLIAVMKN  185

Query  148  AKLDLERTVIRAPADGWVTNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRP  207
            AK+DL+ T + A  +G V ++ V  G  I       A+   ++ ++QA   ET L  V+P
Sbjct  186  AKIDLDETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQANFNETDLRRVQP  245

Query  208  GYRAEITP---LGSNRVLKGTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVR  264
            G +  I P    GS ++  G + S     +   +    +     +S   W  L QR+PV+
Sbjct  246  GDKVSIFPRMYFGS-KIYHGVILSRNWAASRLETHRATQIQIVRNSESNWFLLPQRLPVQ  304

Query  265  IRLDEQQGNLWP--AGTTATVVI  285
            I++ +     +P   G +A V I
Sbjct  305  IQITDYDPVHYPLSIGASAYVYI  327


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 70.9 bits (172),  Expect = 1e-13, Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 111/253 (44%), Gaps = 21/253 (8%)

Query  46   DVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEADVAYYQVLAQEKR  105
            D V I P V+G +  V+  D  LVKK  +LFTID   ++  L  A+A +A  +       
Sbjct  70   DQVDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTA  129

Query  106  QEAGRRNRL-GVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGW  164
                R  RL    A+SR+E+D A N  ++    L  A+A    A+L+LE T I AP  G 
Sbjct  130  SNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGR  189

Query  165  VTNLNVYAGEFITRGSTA---VALVKKNSFYVQAYM-EETKLEGVRPGYRAEITPLGSNR  220
            ++   V  G  ++ G+ A    +LV  +  Y    + E+T L+ +     +   P     
Sbjct  190  ISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSSQVP-----  244

Query  221  VLKGTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWPAGTT  280
                    V  G+ N +  +    + +ID+NL       R  VR   D   G L P G  
Sbjct  245  --------VYMGLANETGFTREGTINSIDNNLNTTSGTIR--VRATFDNPNGVLLP-GLY  293

Query  281  ATVVITGKQDRDA  293
            A + + G Q R A
Sbjct  294  ARIRLGGGQPRPA  306


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 70.9 bits (172),  Expect = 1e-13, Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 111/253 (44%), Gaps = 21/253 (8%)

Query  46   DVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEADVAYYQVLAQEKR  105
            D V I P V+G +  V+  D  LVKK  +LFTID   ++  L  A+A +A  +       
Sbjct  70   DQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTA  129

Query  106  QEAGRRNRL-GVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGW  164
                R  RL    A+SR+E+D A N  ++    L  A+A    A+L+LE T I AP  G 
Sbjct  130  SNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGR  189

Query  165  VTNLNVYAGEFITRGSTA---VALVKKNSFYVQAYM-EETKLEGVRPGYRAEITPLGSNR  220
            ++   V  G  ++ G+ A    +LV  +  Y    + E+T L+ +     +   P     
Sbjct  190  ISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSSQVP-----  244

Query  221  VLKGTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWPAGTT  280
                    V  G+ N +  +    + +ID+NL       R  VR   D   G L P G  
Sbjct  245  --------VYMGLANETGFTREGTINSIDNNLNTTSGTIR--VRATFDNPNGVLLP-GLY  293

Query  281  ATVVITGKQDRDA  293
            A + + G Q R A
Sbjct  294  ARIRLGGGQPRPA  306


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 70.9 bits (172),  Expect = 1e-13, Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 111/253 (44%), Gaps = 21/253 (8%)

Query  46   DVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEADVAYYQVLAQEKR  105
            D V I P V+G +  V+  D  LVKK  +LFTID   ++  L  A+A +A  +       
Sbjct  70   DQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTA  129

Query  106  QEAGRRNRL-GVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGW  164
                R  RL    A+SR+E+D A N  ++    L  A+A    A+L+LE T I AP  G 
Sbjct  130  SNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGR  189

Query  165  VTNLNVYAGEFITRGSTA---VALVKKNSFYVQAYM-EETKLEGVRPGYRAEITPLGSNR  220
            ++   V  G  ++ G+ A    +LV  +  Y    + E+T L+ +     +   P     
Sbjct  190  ISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSSQVP-----  244

Query  221  VLKGTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWPAGTT  280
                    V  G+ N +  +    + +ID+NL       R  VR   D   G L P G  
Sbjct  245  --------VYMGLANETGFTREGTINSIDNNLNTTSGTIR--VRATFDNPNGVLLP-GLY  293

Query  281  ATVVITGKQDRDA  293
            A + + G Q R A
Sbjct  294  ARIRLGGGQPRPA  306


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 70.5 bits (171),  Expect = 2e-13, Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 111/253 (44%), Gaps = 21/253 (8%)

Query  46   DVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEADVAYYQVLAQEKR  105
            D V I P V+G +  V+  D  LVKK  +LFTID   ++  L  A+A +A  +       
Sbjct  70   DQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTA  129

Query  106  QEAGRRNRL-GVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGW  164
                R  RL    A+SR+E+D A N  ++    L  A+A    A+L+LE T I AP  G 
Sbjct  130  SNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGR  189

Query  165  VTNLNVYAGEFITRGSTA---VALVKKNSFYVQAYM-EETKLEGVRPGYRAEITPLGSNR  220
            ++   V  G  ++ G+ A    +LV  +  Y    + E+T L+ +     +   P     
Sbjct  190  ISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQVP-----  244

Query  221  VLKGTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWPAGTT  280
                    V  G+ N +  +    + +ID+NL       R  VR   D   G L P G  
Sbjct  245  --------VYMGLANETGFTREGTINSIDNNLNTTSGTIR--VRATFDNPNGVLLP-GLY  293

Query  281  ATVVITGKQDRDA  293
            A + + G Q R A
Sbjct  294  ARIRLGGGQPRPA  306


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 69.3 bits (168),  Expect = 3e-13, Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 111/253 (44%), Gaps = 21/253 (8%)

Query  46   DVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEADVAYYQVLAQEKR  105
            D V I P V+G +  V+  D  LVKK  +LFTID   ++  L  A+A +A  +       
Sbjct  46   DQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTA  105

Query  106  QEAGRRNRL-GVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGW  164
                R  RL    A+SR+E+D A N  ++    L  A+A    A+L+LE T I AP  G 
Sbjct  106  SNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGR  165

Query  165  VTNLNVYAGEFITRGSTA---VALVKKNSFYVQAYM-EETKLEGVRPGYRAEITPLGSNR  220
            ++   V  G  ++ G+ A    +LV  +  Y    + E+T L+ +     +   P     
Sbjct  166  ISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQVP-----  220

Query  221  VLKGTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWPAGTT  280
                    V  G+ N +  +    + +ID+NL       R  VR   D   G L P G  
Sbjct  221  --------VYMGLANETGFTREGTINSIDNNLNTTSGTIR--VRATFDNPNGVLLP-GLY  269

Query  281  ATVVITGKQDRDA  293
            A + + G Q R A
Sbjct  270  ARIRLGGGQPRPA  282


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 68.6 bits (166),  Expect = 6e-13, Method: Compositional matrix adjust.
 Identities = 55/173 (32%), Positives = 89/173 (51%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+ +     +QT + +L  A        L+L+RT IRAPADG V
Sbjct  183  EESSARAALGGQVSLREQPE-----VQTAIGRLKDAW-------LNLQRTQIRAPADGQV  230

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  231  AKRSVQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  290

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  291  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  338


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 68.2 bits (165),  Expect = 9e-13, Method: Compositional matrix adjust.
 Identities = 55/173 (32%), Positives = 88/173 (51%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+       +QT + +L  A        L+L+RT IRAPADG V
Sbjct  177  EESSARAALGGQVSLREQ-----PAVQTAIGRLKDAW-------LNLQRTQIRAPADGQV  224

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  285  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  332


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 67.8 bits (164),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 55/173 (32%), Positives = 88/173 (51%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+       +QT + +L  A        L+L+RT IRAPADG V
Sbjct  183  EESSARAALGGQVSLREQ-----PAVQTAIGRLKDAW-------LNLQRTQIRAPADGQV  230

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  231  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  290

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  291  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  338


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 67.8 bits (164),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 55/173 (32%), Positives = 88/173 (51%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+       +QT + +L  A        L+L+RT IRAPADG V
Sbjct  177  EESSARAALGGQVSLREQ-----PAVQTAIGRLKDAW-------LNLQRTQIRAPADGQV  224

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  285  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  332


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 67.8 bits (164),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 55/173 (32%), Positives = 88/173 (51%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+       +QT + +L  A        L+L+RT IRAPADG V
Sbjct  177  EESSARAALGGQVSLREQ-----PAVQTAIGRLKDAW-------LNLQRTQIRAPADGQV  224

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  285  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  332


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 67.8 bits (164),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 55/173 (32%), Positives = 88/173 (51%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+       +QT + +L  A        L+L+RT IRAPADG V
Sbjct  177  EESSARAALGGQVSLREQ-----PAVQTAIGRLKDAW-------LNLQRTQIRAPADGQV  224

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  285  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  332


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 67.8 bits (164),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 55/173 (32%), Positives = 88/173 (51%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+       +QT + +L  A        L+L+RT IRAPADG V
Sbjct  183  EESSARAALGGQVSLREQ-----PAVQTAIGRLKDAW-------LNLQRTQIRAPADGQV  230

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  231  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  290

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  291  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  338


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 67.4 bits (163),  Expect = 1e-12, Method: Compositional matrix adjust.
 Identities = 55/173 (32%), Positives = 88/173 (51%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+       +QT + +L  A        L+L+RT IRAPADG V
Sbjct  177  EESSARAALGGQVSLREQ-----PAVQTAIGRLKDAW-------LNLQRTQIRAPADGQV  224

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  285  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  332


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 67.0 bits (162),  Expect = 2e-12, Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 123/313 (39%), Gaps = 81/313 (26%)

Query  26   FRAWVYYTESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTID------  79
            F  W  + E   T DA  +  VV + P   G +  V   D   VKK  VL  +D      
Sbjct  45   FFLWWQHEEE--TEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVL  102

Query  80   --------------QPRYQKA---------------LAEAEADVAYYQVLAQE-------  103
                          Q R Q A               LA A+ D+     LA+        
Sbjct  103  AYERAKNELIQAVRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  104  ------------------KRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATR  145
                                +E+  R  LG Q   RE+       +QT + +L  A    
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVALREQ-----PAVQTAIGRLKDAW---  214

Query  146  DLAKLDLERTVIRAPADGWVTNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGV  205
                L+L+RT IRAP DG V   +V  G+ +  G+  +A+V  +  +V A  +ET+L  +
Sbjct  215  ----LNLQRTQIRAPTDGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHM  270

Query  206  RPGYRAEITP--LGSNRVLKGTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPV  263
            + G  AE+     G   V +G V   +AG  +A S   A+     ++   W+++ QRVPV
Sbjct  271  KIGQPAELVSDLYGKQIVYRGMVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPV  325

Query  264  RIRLDEQQGNLWP  276
            RI L+ +  +  P
Sbjct  326  RIVLNREDVDRHP  338


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 65.9 bits (159),  Expect = 4e-12, Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+       +QT + +L  A        L+L+RT IR PADG V
Sbjct  177  EESSARAALGGQVSLREQ-----PAVQTAIGRLKDAW-------LNLQRTQIRTPADGQV  224

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  285  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  332


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 64.7 bits (156),  Expect = 1e-11, Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 70/129 (54%), Gaps = 7/129 (5%)

Query  150  LDLERTVIRAPADGWVTNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGY  209
            L+L RT +RAPADG V   +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G 
Sbjct  209  LNLRRTQVRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  268

Query  210  RAEITP--LGSNRVLKGTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRL  267
             AE+     G   V +G V   +AG  +A S   A+     ++   W+++ QRVPVRI L
Sbjct  269  PAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVL  323

Query  268  DEQQGNLWP  276
            + +  +  P
Sbjct  324  NREDVDRHP  332


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 63.9 bits (154),  Expect = 2e-11, Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 19/173 (11%)

Query  106  QEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDLERTVIRAPADGWV  165
            +E+  R  LG Q   RE+       +QT + +L  A        L+L+RT IRA ADG V
Sbjct  183  EESSARAALGGQVSLREQ-----PAVQTAIGRLKDAW-------LNLQRTQIRASADGQV  230

Query  166  TNLNVYAGEFITRGSTAVALVKKNSFYVQAYMEETKLEGVRPGYRAEITP--LGSNRVLK  223
               +V  G+ +  G+  +A+V  +  +V A  +ET+L  ++ G  AE+     G   V +
Sbjct  231  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  290

Query  224  GTVDSVAAGVTNASSTSDAKGMATIDSNLEWVRLAQRVPVRIRLDEQQGNLWP  276
            G V   +AG  +A S   A+     ++   W+++ QRVPVRI L+ +  +  P
Sbjct  291  GRVAGFSAGTGSAFSLIPAQ-----NATGNWIKVVQRVPVRIVLNREDVDRHP  338


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 52.0 bits (123),  Expect = 2e-07, Method: Compositional matrix adjust.
 Identities = 47/163 (29%), Positives = 73/163 (45%), Gaps = 6/163 (4%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV  193
             R+ I AP  G++    V  G  +  G T V   + + N  YV
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 52.0 bits (123),  Expect = 2e-07, Method: Compositional matrix adjust.
 Identities = 47/163 (29%), Positives = 73/163 (45%), Gaps = 6/163 (4%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV  193
             R+ I AP  G++    V  G  +  G T V   + + N  YV
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 51.6 bits (122),  Expect = 2e-07, Method: Compositional matrix adjust.
 Identities = 47/163 (29%), Positives = 73/163 (45%), Gaps = 6/163 (4%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV  193
             R+ I AP  G++    V  G  +  G T V   + + N  YV
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 50.8 bits (120),  Expect = 5e-07, Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (45%), Gaps = 9/175 (5%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV---QAYMEETKL  202
             R+ I AP  G++    V  G  +  G T V   + + N  YV   Q+  E  KL
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKL  233


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 50.8 bits (120),  Expect = 5e-07, Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (45%), Gaps = 9/175 (5%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV---QAYMEETKL  202
             R+ I AP  G++    V  G  +  G T V   + + N  YV   Q+  E  KL
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKL  233


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 50.8 bits (120),  Expect = 5e-07, Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (45%), Gaps = 9/175 (5%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV---QAYMEETKL  202
             R+ I AP  G++    V  G  +  G T V   + + N  YV   Q+  E  KL
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKL  233


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 50.8 bits (120),  Expect = 5e-07, Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (45%), Gaps = 9/175 (5%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV---QAYMEETKL  202
             R+ I AP  G++    V  G  +  G T V   + + N  YV   Q+  E  KL
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKL  233


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 50.4 bits (119),  Expect = 5e-07, Method: Compositional matrix adjust.
 Identities = 47/163 (29%), Positives = 73/163 (45%), Gaps = 6/163 (4%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV  193
             R+ I AP  G++    V  G  +  G T V   + + N  YV
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 50.4 bits (119),  Expect = 5e-07, Method: Compositional matrix adjust.
 Identities = 47/163 (29%), Positives = 73/163 (45%), Gaps = 6/163 (4%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV  193
             R+ I AP  G++    V  G  +  G T V   + + N  YV
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYV  221


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 50.4 bits (119),  Expect = 6e-07, Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (46%), Gaps = 9/175 (5%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQ  118

Query  94   VAYYQV-LAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +  +A+SR+E D A    ++    +  AQA    A + L
Sbjct  119  LATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRG-STAVALVKK-NSFYV---QAYMEETKL  202
             R+ I AP  G++    V  G  +  G +T +A +++ N  YV   Q+  E  KL
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKL  233


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 49.7 bits (117),  Expect = 9e-07, Method: Compositional matrix adjust.
 Identities = 50/175 (29%), Positives = 77/175 (44%), Gaps = 9/175 (5%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +   A+S++E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVSADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV---QAYMEETKL  202
             R+ I AP  G++    V  G  +  G T V   + + N  YV   Q+  E  KL
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKL  233


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 49.7 bits (117),  Expect = 9e-07, Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 72/163 (44%), Gaps = 6/163 (4%)

Query  34   ESPWTRDARFSADVVAIAPDVAGLITHVNVHDNQLVKKDQVLFTIDQPRYQKALAEAEAD  93
            E P   ++  +ADV A    V G+I      +   V+  Q L+ ID   Y+  L  A A 
Sbjct  62   ELPGRLESLRTADVRA---QVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQ  118

Query  94   VAYYQ-VLAQEKRQEAGRRNRLGVQAMSREEIDQANNVLQTVLHQLAKAQATRDLAKLDL  152
            +A  Q  LA+     A  +  +   A+S++E D A    ++    +  AQA    A ++L
Sbjct  119  LATAQATLAKADADLARYKPLVSADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGINL  178

Query  153  ERTVIRAPADGWVTNLNVYAGEFITRGSTAV--ALVKKNSFYV  193
             R+ I AP  G++    V  G  +  G T V   + + N  YV
Sbjct  179  NRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYV  221



Lambda      K        H        a         alpha
   0.319    0.131    0.370    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2205038430


  Database: VFDB_setB_pro.fas
    Posted date:  Apr 10, 2024  11:56 PM
  Number of letters in database: 13,298,383
  Number of sequences in database:  27,982



Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Neighboring words threshold: 11
Window for multiple hits: 40
